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Abstract 
Salmonella serovars are facultative, intracellular gastrointestinal pathogens responsible for 
causing diseases ranging from diarrhea and enterocolitis to severe, systemic fatal infections in 
humans and animals, and represent a major public health and economic burden worldwide. 
Within infected host cells, Salmonella resides within a membrane-bound compartment called 
the Salmonella-containing vacuole (SCV). Formation of the SCV has been reported both in 
epithelial and macrophage cells. The SCV has been regarded as a nutrient deprived 
compartment because of its isolation from both extra- and intracellular sources of nutrients. 
However, despite apparent nutrient limitation within the SCV, Salmonella is still able to 
replicate in the SCV, indicating adaptation to this intracellular environment. 
 Despite rapid progress in understanding the molecular functions of virulence factors of 
Salmonella involved in intracellular survival and replication, a fundamental question 
regarding the source(s) of nutrients for growth of Salmonella within the SCV is still not 
completely understood. Our study shows that Salmonella Typhimurium acquires small 
peptides by co-opting the host cell cytosolic protein turnover pathway known as chaperone-
mediated autophagy (CMA). CMA is a selective host cell protein turnover pathway active in 
all cell types and is involved in the transport of cytosolic proteins into lysosomes for 
degradation. An estimated 30% of all cytosolic proteins are turned over through this 
mechanism. Here we show for both intracellular Salmonella and in purified SCVs that the 
SCV is associated with the key components of the CMA, LAMP-2A and Hsc73 and upon 
inhibiting CMA either by chemical inhibitors or by knocking down LAMP-2A in cells affects 
the intracellular growth of peptide-dependent mutants of Salmonella. Furthermore, the SCV 
selectively associated with CMA components and excludes association with liposomal 
markers suggesting no interaction with the lysosomes. Furthermore, for our studies we have 
also developed a novel method for isolating intact SCV using paramagnetic nanoparticles. 
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 The results of this study highlight a unique phenomenon in host-pathogen interaction 
wherein an intracellular pathogen monitors the fitness of their infected host cells and are able 
to couple their own intracellular proliferation rate to the health status of the host.
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Zusammenfassung 
Verschiedene Serovare der Spezies Salmonella sind fakultativ intrazelluläre gastrointestinale 
Pathogene. Sie sind ursächlich für eine Reihe von Erkrankungen wie Salmonellose, Diarrhö, 
Enterokolitis sowie schwerwiegenden systemischen Infektionen bei Mensch und Tier. 
Salmonella stellt daher ein bedeutendes Public Health Problem dar und verursacht weltweit 
einen hohen ökonomischen Schaden.  
Ähnlich wie bei anderen intrazellulären Pathogenen befindet sich Salmonella innerhalb von 
infizierten Wirtszellen in einem durch Membranen abgetrennten Kompartiment, der 
sogenannten “Salmonella-Containing Vacuole (SCV)“. Das Vorhandensein dieser SCV wurde 
sowohl in Epithel- als auch in Makrophagen-Zellen beobachtet. 
Da das Innere dieser SCV sowohl von intrazellulären als auch von extrazellulären 
Nährstoffquellen abgeschnitten ist, geht man von einem Nährstoffmangel in diesem 
Kompartiment aus. Trotz dieses offensichtlich vorliegenden Nährstoffmangels bleibt 
Salmonella aber in der Lage sich innerhalb der SCV zu replizieren. Dies spricht für eine 
erfolgreiche Adaptation an die Bedingungen dieses intrazellulären Milieus. 
 Trotz des umfangreichen Wissens über den intrazellulären Status von Salmonella und 
den dabei involvierten Virulenzfaktoren sowie deren molekularen Funktionen, ist die Art der 
Nährstoffquelle welche Salmonella innerhalb der SCV nutzt bisher noch nicht völlig geklärt. 
In unserer Studie konnten wir allerdings zeigen das Salmonella Typhimurium mit dem 
wirtseigenen „Cell Chaperone mediated Autophagy (CMA)“-abhängigen zytosolischen 
Protein-Metabolismus interagiert. Bei CMA handelt es sich um einen wirtszelleigenen 
selektiven Protein-Stoffwechselweg der in allen Zelltypen vorkommt. Er dient dem Transport 
von zytosolischen Proteinen in die Lysosomen wo sie dann abgebaut werden.  
So werden ca. 30% des zytosolischen Proteins über diesen Mechanismus metabolisiert. In 
unseren Arbeiten konnten wir sowohl für intrazelluäre Salmonella als auch für aufgereinigte 
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SCVs zeigen das diese mit Kernkomponenten des CMA-Systems wie LAMP-2A und Hsc73 
assoziiert sind.  
 Des weiteren konnten wir zeigen das CMA entweder direkt über chemische 
Inhibitoren oder den Knock Down von LAMP-2A in den Zellen beeinflusst werden konnte 
was das intrazelluläre Wachstum von peptid-abhängigen Salmonella Mutanten beeinflusste. 
Weiterhin waren die SCVs ausschließlich mit CMA Komponenten und nicht mit liposomalen 
Markern assoziiert, was gegen eine Interaktion mit den Lysosomen spricht. Zusätzlich wurde 
eine neue Methode zur Isolation intakter SCV mittels paramagnetischer Nanopartikel 
entwickelt.  
 Die Ergebnisse dieser Studie zeigen ein einzigartiges Phänomen auf dem Gebiet der 
Wirt-Pathogen- Wechselwirkung bei dem ein intrazelluläres Pathogen die Fitness der 
infizierten Wirtszelle überwacht und in der Lage ist seine eigene intrazelluläre 
Proliferationsrate an den Gesundheitsstatus der Wirtszelle zu knüpfen.  
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Abbreviations 
APS  Ammonium peroxidisulfate 
bp  Base pairs 
BCA 2,2´Bicinchoninic acid 
BSA Bovine serum albumin (Fraction V) 
C Celsius 
Cat Chloramphenicol acetyl transferase 
cDNA Complementary DNA 
cfu Colony forming units 
Cu Copper 
DCE Anhydrous 1,2-dichloroethane  
DMEM Dulbecco’s modified eagles medium 
DMSO Dimethyl sulphoxide 
DNA Deoxyribonucleic acid 
DNase Deoxyribonuclease 
dNTPs Deoxyribonucleoside triphosphates 
DTT Dithiothreitol 
E. coli Escherichia coli 
EDTA Ethylenediamino tetraacetic acid 
EEA1 Early endosomal antigen 1 
EGTA Ethylene-glycol-bis (2-aminoethyl) tetraacetic acid 
FCS Fetal Calf Serum 
Fig. Figure 
GFP Green Fluorescent protein 
h Hours 
IPTG Isopropyl-thio-ß-D-galactopyranoside 
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kb Kilo base 
Km Kanamycin 
LB Lennox broth 
lgps lysosomal gycoproteins 
LPS Lipopolysaccharide 
LTTR LysR-type transcriptional regulator 
m Milli 
M Molar 
µ Micro 
OD Optical density 
ONPG o-Nitrophenyl-β-D-galactopyranoside 
ORF Open reading frame 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PI Pathogenicity island 
p.i. post-infection 
PMSF Phenylmethylsulphonylflouride 
ppGpp Guanosine tetraphosphate 
RNA Ribonucleic acid 
RNase Ribonuclease 
rpm Revolutions per minute 
RT Room temperature 
RT-PCR Reverse-Transcriptase Polymerase Chain Reaction 
SCV Salmonella-containing vacuole 
SDS Sodium dodecylsulfate 
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SIF Salmonella-induced filament 
SPI Salmonella pathogenicity island 
TBE Tris-borate-EDTA 
TEMED N,N,N’,N’-Tetramethylethylenediamine 
Tc Tetracycline  
TRIS 2-Amino-2-hydroxymethyl-1,3-propandiol 
T3SS Type III secretion system 
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Introduction 
Salmonellosis 
Salmonella enterica is a Gram-negative intracellular bacteria belonging to the 
Enterobacteriaceae and which is responsible for gastrointestinal diseases upon ingestion of 
contaminated food and water. Salmonella is a pathogen is of high clinical relevance in both 
developing and developed nations causing food-borne illness and other diarrheal diseases as 
well as severe systemic infections and economic losses. Many serovars of Salmonella can 
infect and colonize a wide variety of hosts, with outcomes ranging from sub-clinical 
infections to life threating systemic fatal disease (Jones et al., 2008a; Lahiri et al., 2010). 
Salmonella has been successfully isolated both form warm blooded and cold blooded animals 
(Fookes et al., 2011; Schikora et al., 2011), furthermore, several sub-species of Salmonella 
are known to infect plants. Hence Salmonella is often considered as a ‘universal pathogen’ 
(Fedorka et al., 2000).  
 Salmonella as pathogen posses a very high zoonotic potential with millions of fresh 
human cases reported every year. According to a report by Centre for Disease Control, (CDC, 
2013) in the US alone, approximately, 40,000 cases of Salmonella are reported each 
year.Furthermore, of the total report cases, the severity of infection predominates in children, 
the immunocompromised individuals and the old aged, leading to death of nearly 400 persons 
every year as a result of acute Salmonellosis. In the European Union, infections due to 
Salmonella are the second most reported bacterial diseases in humans after Campylobacter 
infections (EFSA and ECDC, 2013 Summary report on Zoonosis). In the developing and third 
world countries, Salmonella serovars are responsible for numerious outbreaks within a year 
thus signifying the frequency with which these serovars persist and cause infections in the 
environment (Kariuki et al., 2006; Kozak et al., 2013). Both in United States and European 
Union, reported human cases of salmonellosis are frequently related to S. enterica serovar 
Typhimurium and S. enterica serovar Enteritidis (CDC, 2011-National Salmonella 
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Surveilance Annual Data Summary 2009; EFSA and ECDC, 2013-Summary report on 
Zoonosis). Salmonella serovar Enteritidis cases are principally related to contaminated eggs 
and poultry meat. However, Salmonella serovar Typhimurium infections are also the result of 
consumption of contaminated meat products from pigs, bovine and poultry. Thus, Salmonella 
infections or Salmonellosis remains a major health burden and represents a significant health-
related and economic cost to society. 
The genus Salmonella 
The genus Salmonella was discovered by an American veterinary pathologist, Daniel Elmer 
Salmon, in 1885. The genus Salmonella refers to facultative, anaerobic intracellular bacteria 
which exhibit predominant peritrichous motility. Salmonella are Gram-negative, rod shaped, 
non-spore forming bacteria, with diameter ranging from 0.7 to 1.5µm and a length of 2 to 
5µm belonging to Enterobacteriaceae family (Murray et al., 1999; Coburn et al., 2007).  The 
genus Salmonella is closely related to Escherichia, however horizontal gene transfer has 
played an instrumental role in its divergence from the E. coli lineage (Baümler et al.,1998; 
Retchless and Lawerence, 2010) through acquisition of virulence determinants, pathogenicity 
islands and plasmids favouring Salmonella infection and adaptation to a wide range of hosts. 
Notably, horizontal gene transfer is responsible for acquisition of Salmonella-Pathogenecity 
island-1 (SPI-1), encoding virulence genes and factors, interestingly, it is absent in E. Coli 
and other non pathogenic Gram negative bacteria (Collazo and Galan, 1997). The SPI-1 
encoded gene and virulence proteins are responsible for the invasion of Salmonella within 
host cells (Miller et al., 1995; Hensel 2004). 
Classification 
The WHO collaborating Centre for Reference and Research on Salmonella at the Pasteur 
Institute, Paris France, maintains and updates the classification of the genus Salmonella based 
on the Kauffmann-White scheme of serotyping (Grimont and Weill, 2007). The genus 
Salmonella consists of two species, Salmonella enterica and Salmonella bongori. The species 
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S. enterica is further divided into six sub-species namely, S. enterica subsp.enterica (I), S. 
enterica subsp. salame (II), S. enterica subsp. arizoniae (IIIa), S. enterica subsp. diarizonae 
(IIIb), S. enterica subsp. houtenae (IV) and, S. enterica subsp. indica (VI) as shown in Figure 
1. The species S. enterica has acquired a second pathogenicity island, SPI-2, responsible for 
establishing a replicative niche for the pathogen within its host (Retchless and Lawerence, 
2010). S. bongori subsp. (V), as well as subspecies II, IIIa, IIIb, IV and VI are principally 
isolated from cold-blooded vertebrates and the environment. The S. enterica subsp. enterica 
(I), is mainly responsible for causing infections and diseases in humans and other domestic 
animals (Fierer and Guiney, 2001; Lan et al., 2005).  
 
Figure 1. Overview of the current classification of Salmonella enterica. The figure represents classification of 
the genus Salmonella, which is divided into two species Salmonella bongori and Salmonella enterica based on 
biochemical and serological assays further confirmed by MLST typing. The species enterica is further classified 
into six sub-species; the sup-species-I enterica consists of numerious serovars which causes of infections to 
humans and other animals. Depending upon the disease syndrome and severity of infections these serovars could 
further be grouped into Typhoidal causing serovars and Non-Typhoidal Salmonella. (Achtman, et al., 2012; 
under free license agreement). 
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S. enterica strains can further be classified into serogroups and serotypes (serovars) based on 
the presence of surface antigens. On the basis of the O surface antigen alone 
(lippolysachcharide, LPS), S. enterica can be classified into nearly 65 serogroups and into 
2500 serovars when these strains are differentiated by presence of both O (LPS) and H 
(flagellar) antigens. Among these, about 1500 serovars belong to the subspecies I of S. 
enterica (Grimont and Weill, 2007; CDC, 2011-National Salmonella surveillance overview). 
Furthermore, serovars belonging to S. enterica subsp. enterica (I) can further be broadly 
divided into two groups as shown in Figure 1, namely Typhoidal Salmonella, which causes 
systemic typhoidal diseases and Non-Typhoidal Salmonella (NTS). The NTS serovars are 
largely associated with self-limiting gastroenteritis and bacteremia in humans and animals 
(Achtman et al., 2012). 
Clinical Relevance and treatment 
Salmonella infections in humans are responsible for causing two clinical syndromes mainly 
typhoid or enteric fever and colitis or diarrheal disease depending upon the serovar that is 
responsible for infection. Serovars such as Salmonella Typhi, Salmonella Paratyphi A and B 
cause systemic illness in humans, with clinical manifestations including enteric fever, 
abdominal pain, headache, transient constipation. Prolonged infections can result in severe 
hepatic, spleen, respiratory or neurological damage. Untreated, these infections result in high 
mortality rates of 20-25% (Miller et al., 2001; Parry et al., 2002). 
NTS serotypes such as S. Enteritidis and S. Typhimurium are the most frequent causative 
agents of diarrheal diseases in humans and animals across the globe. According to WHO 
statistical data, S. Enteritidis globally accounted for 65% and S. Typhimurium for 12% 
infections of all human isolates. In contrast, S. Typhimurium was the most frequent reported 
serovar among non-human isolates, accounting for 17% of the total isolates (Galanis et al., 
2006). 
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The severity of infections caused by NTS serotypes in an immunocompetant individual is 
more drastic and often accounts for high mortality rates. NTS infections if untreated have a 
fatality rate of 0.1% to 0.5 % in developed countries in patients suffering from previous 
gastric surgery, diabetes and HIV (Gordon 2008 and Hohmann 2001). On the other hand, the 
mortality rate is relatively high in third world and developing countries, accounting for nearly 
24% deaths per year. Such high death rates are mostly attributable to economic factors 
contributing to poor hygiene conditions (Feasey et al., 2012). In third world countries, 
children often suffer from malnutrition and are often prone to Salmonella infections resulting 
in hospital admissions at a very early age with symptoms of bloody diarrhea and bacteremia 
in > 20% of cases, and high rates of complications (Mandomando et al., 2009 and 
Chimalizeni et al., 2010; Feasey et al., 2012). 
NTS infections often result in a carrier state due to persistent colonization of the pathogen in 
the gut in both humans and livestock. These carrier hosts play a vital role in propagation of 
the diseases and act as reservoirs with high zoonotic potential as the infections are often 
asymptomatic, with little or no obvious clinical characteristics (Crawdord et al., 2010; 
Chausse et al., 2011). As reported by previous studies, only 5x104 bacteria when ingested 
either through contaminated water or food are capable enough to cause Salmonellosis and 
other gasterointestinal illnesses (Wray and Sjoka 1978). However, 5% of the infected 
individuals develop bacteremia Furthermore; young children suffering from pre-existing 
medical conditions such as malaria and malnutrition are also more frequently infected 
(Lightfoot et al., 1990). 
Treatment 
Depending upon the severity of illness and physiological condition of the patient, different 
strategies could be adopted against the pathogen. The majority of gut-limited NTS infections 
often result in substantial loss of body fluid, thus in such cases it is important to maintain the 
electrolyte balance. Therefore, such patients are often provided with either oral or intravenous 
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rehydration so as to counteract the fluid loss (Hohmann 2001). In contrast, in patients with 
high risk factors and severe illness due to high invasion rates are often put on antimicrobial 
therapy (Coburn et al., 2007). Outbreaks of Salmonellosis due to fecal shedding are controlled 
by the use of antibiotics (Lightfoot et al., 1990). Antibiotics such as ampicillin, 
fluoroquinolones, cephalosporins (cefixime or ceftriaxone) or trimethoprim-sulfamethoxazole 
(TMP-SMZ) are highly efficient for treating large scale Salmonella infections. However, the 
overuse of these antibiotics has also resulted in antibiotic resistance among S. Typhimurium. 
Furthermore, multiple antimicrobial resistance has been reported in S. Typhimurium where 
>55% of total isolates were found to be multi-drug resistance (MDR) (Erdem et al., 2005; 
Weill et al., 2006,). In addition, the acquisition of phage type DT104 and other hybrid 
plasmids have resulted in ACSSuT (ampicillin, chloramphenicol, streptomycin, sulfonamides 
and tetracycline) type resistance, conferring resistance against nearly all available antibiotics 
and which has posed a problem in the medical as well as veterinary communities (Cloeckaert 
and Schwarz 2001; Antunes et al., 2004; Herrero et al., 2008; Herrero et al., 2009). 
Salmonella serovars and their host specificity 
Salmonella serovar host specificity refers to the differences among Salmonella serovars in 
terms of the type of infections (or lack of infection) they cause for a given host. Salmonella 
serovars exhibit specificity towards their preferred host. The preference for a particular host 
highlights the ability of a serovar to adapt to a particular host. Depending upon numerous 
factors including the surrounding environment and immunological state of the host 
(Thinnimitr et al., 2012), the dose of infection and the biological age during which the host is 
infected (Kingsley and Baumler, 2000), the severity of infection caused by the same serovar 
varies drastically. Even after the availability of complete genome sequences of several 
Salmonella serovars, it is still unclear what mechanism make one serovar more virulent in 
towards a particular host while making it completely non pathogenic or less virulent into 
another, thus making the serovar specific towards that host. 
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 The serovars of S. enterica subspecies I have been characterized into three groups on 
the basis of their ability to colonize various hosts and the severity of infections caused within 
these hosts. These include the unrestricted, host-adapted and host-restricted groups as 
summarized in Table 1. The serovars of the unrestricted group infect a wide range of hosts, 
generally causing mild, enteric diseases. Epidemiologically, these serovars represent a high 
risk zoonotic reservoir as they have developed mechanisms to infect different hosts and 
persist without necessarily evoking severe clinical symptoms (Clarke et al., 1993). 
Table1. Host specific characterization of Salmonella Serovars (Adopted from Vikash Singh, 2013; 
under free license agreement). 
 
Serovars such as Salmonella Typhimurium and Salmonella Enteritidis belong to this group. 
Serovars of the host-adapted group infect and cause high rates of systemic infection in their 
preferred hosts, but are usually excreted (shed) without significant clinical symptoms in other 
hosts. For example, serovars Salmonella Choleraesuis and Salmonella Dublin often cause 
fatal systemic infections in swine and cattle, respectively (McCuddin et al., 2008). However, 
these are usually isolated as gastrointestinal pathogens and excreted in rodents and humans. 
The third group is comprised of serovars such as Salmonella Typhi, Salmonella Paratyphi, 
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and Salmonella Gallinarium/Pullorum which are restricted to infections of one specific host. 
These serovars have been suggested to modulate their host environment in such a manner 
which favors their own growth and characterised by a high trophism towards lymphatic 
organs of their host (Uzzau et al., 2001). The serovars representing the host-restricted group 
are responsible for causing fatal systemic infections 
Factors determining host specificity 
Successful adaptation to a host by any pathogen is a complex process as it involves numerous 
factors and genetic determinants which are a result of large number of gene products. The 
very basic strategies or characteristics that have been observed whereby pathogens adapt in 
order to establish themselves within their host involves either acquisition of novel virulence 
determinants and plasmids or a tendency toward genome reduction (Brendan, 2000). Serovars 
such as a Salmonella Typhimurium, Enteritidis, Pullorum, Gallinarium Dublin and Paratyphi 
C are classic examples which have undergone gene deletions (Clarke et al., 1993). As a result, 
serovars like Cholerasuis and Paratyphi C have lost the ability to replicate in the intestinal 
lumen of their respective host, although these successfully cause systemic infections (Chiu et 
al., 2005). Apart from gene deletions, horizontal gene transfer has led to acquisition of 
virulence factors, which have contributed significantly in host adaptation of Salmonella 
serovars. Attachment to host cell surface is a pre-requisite parameter to be considered for a 
successful invasion of Salmonella with in its host. Mannose-sensitive pathogenicity 
determinants such as FimH-like adhesins play an important role in adhesion of Salmonella to 
its host cell surface (Guo et al., 2009). Allele variations or point mutations resulting in 
structural modification of these adhesions could be an important determining factor leading to 
changes in host-specificity (Guo et al., 2009). For example, type I FimH adhesions are found 
to be expressed by unrestricted serovars which infect both mammals as well as chickens, 
however, type-2 FimH adhesions are expressed only by host-restricted serovars such as 
Salmonella Gallinarium (Guo et al., 2009). 
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 In addition to genetic factors, other factors such as physiological state of host cell, the 
availability of amino acids and the ability of one serovar to compete with others or the 
endogenous microbiota, can also play a role in the virulence pattern of a serovar (Tierrez and 
Portillo, 2005). For example, in animal infection studies, S. Typhimurium showed a more 
rapid replication in swine ileal mucosa relative to the swine-adapted serovar S. Choleraesius. 
However, as a result of its rapid replication, S. Typhimurium infection also resulted in 
elevated and sustained immune responses leading to its faster clearance, whereas the slow-
growing S. Choleraesius showed reduced host immune responses, but was successfully able to 
disseminate, eventually leading to systemic infections in swine (Paulin et al., 2007). 
Salmonella and its host 
Salmonella pathogenicity islands and other virulence determinants 
Salmonella has acquired a large number of virulence genes and other pathogenicity 
determinants via horizontal gene transfer (Hall, 2010; Jacobsen et al., 2011). The majority of 
the genes encoding for these virulence factors are located either within highly conserved, 
genomic sequences known as Salmonella pathogenicity islands (SPIs), or are found on stably 
inherited virulence plasmids such as pSLT (Jones et al., 1982). At least 60 chromosomally-
encoded virulence genes located on different pathogenicity islands have been reported to 
mediate host cell invasion and intracellular survival and replication. Thus far, at least 12 SPIs 
have been found in genome sequences of various Salmonella serovars, many of them being 
found in all genomes within Salmonella enterica subsp. enterica, with the exceptions of SPI-6 
and SPI-7 which have only been reported in Salmonella Typhi (Jacobsen et al., 2011). In 
addition to the five major SPIs in Salmonella Typhimurium, other virulence components such 
as the pSLT plasmid, fimbrial/adhesin genes and flagella also contribute significantly in 
determining the virulence of the pathogen (Jones et al., 1982; Marcus et al., 2000).  
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Salmonella pathogenicity island-1 (SPI-1) 
SPI-1 encodes gene target products responsible for host cell invasion, particularly epithelial 
cells, by modulating the host cytoskeleton arrangement and mediating actin polymerization. 
SPI-1 comprises a 40kb region located at centosome 63 (Miller et al., 1995; Hensel 2004), 
and which harbours at least 35 genes encoding for a type-III secretion system, often termed as 
T3SS-1 (Kimbrough and Miller, 2002), as well as effector proteins which are injected into the 
host cell cytoplasm. Numerous operons located within SPI-1 encode for different structural 
components of a functional T3SS. The inv/spa and the prg/org operons encode the core 
component and needle complex proteins, respectively (Collazao and Galan 1997, Klein et al., 
2000; Sukhan et al., 2001). The spc/sip operon encodes effector proteins and the translocon 
composed of the SipB, SipC and SipD proteins which form a pore-forming structure 
embedded in the host cell membrane and which transport the effector proteins into the host 
cytosol (Kimbrough and Miller 2002). Additionally, SPI-I also encodes for several 
chaperones which bind to their specific target effector proteins thereby protecting them from 
degradation, preventing their premature interaction and also unfolding them in a manner 
which allows their easy translocation through the needle complex into the host (Zurawski et 
al., 2004; Dai and Zhou, 2004; Ruiz et al., 2004). 
Salmonella pathogenicity island-2 (SPI-2) 
Salmonella pathogenicity island-2 (SPI-2) is a 40 kb sequence region, which is divided into 
two segments, a 15kb smaller segment and 25kb larger segment. The 15kb smaller segment is 
present in both Salmonella species bongori and enterica, and it contains the ttRSBCA operon 
which is involved in tetrathionate reduction (Hensel et al., 1999). Additionally, it also has 
seven open reading frames (ORFs) whose function is yet to be deciphered. Conversely, the 
larger 25 kb region is restricted to subspecies of Salmonella enterica and encodes a second 
T3SS, which functions to secrete effector proteins involved in enabling Salmonella to survive 
and replicate within a membrane-bound compartment within infected host cells called the 
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Salmonella-Containing vacuole (SCV; Hensel et al., 1995; Ochman et al., 1996). SPI-2 
harbours four types of genes whose designations are related to their functions and play an 
essential role in virulence: ssr encoding the regulator; ssa, genes for T3SS-2 apparatus; ssc 
encoding the chaperones and sse encoding the effector proteins (Marcus et al., 2000; Kuhle 
and Hensel, 2004). 
Other pathogenicity islands 
Salmonella Typhimurium harbours 3 additional pathogenicity islands, SPI-3, SPI-4 and SPI-
5. These 3 pathogenicity islands have not yet been studied in detail, thus little is known about 
their function(s). SPI-3, is a 17kb region, acquired through horizontal gene transfer and is 
conserved in both Salmonella Typhimurium and Salmonella Typhi. SPI-3 encodes for mgtCB 
operon whose gene products facilitate bacterial survival in macrophages (Blanc-Potrad and 
Groisman, 1997). SPI-4 represents a 27kb region inserted at 92 minutes on Salmonella 
Typhimurium chromosome (Wong et al., 1998). Originally, 18 open reading frames (ORFs) 
were identified with in this island but after completion of the Salmonella Typhimurium LT2 
genome sequence, these were re-annotated to indicate only 6 ORFs (McClelland et al., 2001). 
SPI-5 represents a 7.6 kb region which is conserved among all Salmonella serovars. It 
encodes for the SopB/SigD effector proteins which are secreted by SPI-1 T3SS and play a 
role in actin polymerization. SPI-5 also encodes for pipA, B, C, D and orfX gene products 
(Wood et al., 1998). The gene product of genes pipA and pipB is translocated via the T3SS-2 
into the host cell and PipA have been reported to play an essential role in the development of 
systemic infection in mice (Knodler et al., 2002).  PipB is reported to localize in the 
intracellular lipid rafts present on the SCV membrane (Knodler et al., 2003). PipC act as a 
chaperone for the transporter protein SigE (Knodler et al., 2005; Patel and Galan, 2006).  
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Plasmid-encoded virulence factors 
Among all Salmonella serovars, only a few clinically important serovars such as Salmonella 
Typhimurium, S. Enteritidis, S. Choleraesuis and S. Dublin harbour a serovar-specific 
virulence plasmid. These plasmids encode virulence-associated gene which are known to play 
a significant role during the later stages of infection process and contribute to the intracellular 
growth at sites beyond the intestine, as shown in various mice infection models (Gulig, 1990; 
Guling and Doyle, 1993). Depending upon the serovar, the virulence plasmids usually ranges 
from 55 to 95kb. All serovars positive for the virulence plasmid share an 8-kb conserved 
region encoding 5 genes, spvRABCD, and which are transcribed as an operon. SpvR is a 
positive transcriptional regulator which regulates the expression of other genes on the operon 
in response to low pH and nutrient limited conditions (Guiney et al., 1995). SpvB and SpvC 
are the only encoded effector proteins in the operon. SpvC is responsible for pro-
inflammatory response of the host (Mazarkiewicz et al., 2008), wheras SpvB is a cytotoxic 
protein whose role is related to later intracellular stages of infection process (Matsui et al., 
2001).  
In addition to the pSLT-type plasmid, other plasmids have also been reported which harbour 
antimicrobial resistance genes and are usually of larger size. For instance, Salmonella 
Typhimurium has been found to harbour hybrid plasmids, such as pUO-stRV2, which is 
approximately 140kb in size and may have orginated from the pSLT plasmid with acquisition 
of a complex, antimicrobial locus involved in multiple antibiotic resistance of Salmonella 
Typhimurium (Guerra et al., 2002; Herrero et al., 2008).  
Intestinal invasion by Salmonella 
Salmonella Typhimurium infections are generally caused by the ingestion of bacteria in 
contaminated food and water. Upon ingestion, the first obstacle that the pathogen has to 
overcome within the host is the acidic pH of the stomach. In order to protect itself against this 
acidic shock, Salmonella Typhimurium activates the acid tolerance response (ATR) which 
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makes the intracellular pH within Salmonella much higher to that of extracellular 
environment (Foster and Hall, 1991). The bacterium then reaches the small intestine where it 
transverse through the intestinal mucosal layer before adhering to the intestinal epithelial 
cells. Salmonella thrives on the Payer’s patches, which are abundant with specialized 
epithelial M (microfold or membranous) cells, which are considered the initial or primary site 
for infection (Takeuchi, 1967; Jones et al., 1994).  In vivo studies have shown that Salmonella 
can be found within M cells as early as 5 min. post-infection (Schauser et al., 2004; Morgan 
et al., 2004). On adherence to M cells, Salmonella brings about significant physical changes 
in the cell. The bacterium induces cytoskeleton rearrangement at the apical surface of M cells 
resulting in bacterial internalization (Finlay et al., 1991). However, unlike other invasive 
gastrointestinal pathogens such as Shigella or Yersinia which are dependent upon M cells in 
order to breach the intestinal epithelial barrier (Jones et al., 1995; Jensen et al., 1998), 
Salmonella infection/invasion of the host is independent of M cells (Lee and Falkow, 1993).  
 Salmonella has developed mechanisms to invade, survive and proliferate both in 
phagocytic and non-phagocytic cells. Salmonella successfully infects epithelial cells, 
macrophages, dendritic cells, enterocytes and neutrophils (Lara-Tejero and Galan, 2009). The 
pathogen employs different strategies to mediate its entry into host cells. Salmonella could 
enter either by phagocytosis, through its T3SS-1 dependent or T3SS-1 independent pathways 
(Collazo and Galan, 1997).  Bacterial invasion characterized by T3SS-1 results in secretion/ 
injection of SPI-I encoded effector proteins directly into the epithelial cells cytoplasm. These 
effector proteins bring about actin polymerization and tampers with the host cytoskeleton in 
the process mediating the bacterial entry by macro-pinocytosis (Galan, 1998). Some of the 
SPI-1 secreted effector proteins that are required for bacterial internalization are SipA, SopB, 
SopA, SopD, SopE and SopE2 (Raffatellu et al., 2005). The effector proteins SopB, SopE and 
SopE2 activate Rac1, Cdc42 and Rho-family GTPases. The activation of Cdc42 and Rac1 
leads to recruitment of WASP and Scar/WAVE family of proteins and these together with the 
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Arp2/3 complex initiates the actin polymerization (Hardt et al., 1998). SipC, when secreted, 
anchors itself within the inner membrane of the host cell and serves as a site for nucleation 
and bundling of free, cytosolic actin. SipA mediates actin filament polymerization and 
increases the stability of the resulting actin filaments (Srikanth et al., 2001; Haraga et al., 
2008).  The role of the key effector proteins is highlighted in Table 2, which play an important 
role in the biogenesis of the SCV (Ramos-Morales, 2012). 
 In addition to SPI-1-mediated host cell invasion, fimbriae and flagellae also contribute 
towards Salmonella’s entry into epithelial cells (Chessa et al., 2009). Mutations in the tdcA 
gene affect flagellar biosynthesis in Salmonella Typhimurium and these mutants are reported 
to be less invasive and show reduced growth in epithelial cells (Lim et al., 2010).  Fimbriae 
facilitate the attachment between the bacteria and the host epithelial cell by binding to the 
extracellular matrix of the epithelial cells (Kukkonen et al., 1993; Baumler et al., 1997).  
Another important factor which plays a role in invasion of Salmonella into epithelial cell is O 
antigen length in the lipopolysaccharide (Holzer et al., 2009). 
 After breaching the intestinal epithelial wall, the bacterium reaches the mesenteric 
lymph node (MLNs) via intestinal lymph through professional phagocytic cells such as 
macrophage and dendritic cells (Vazquez-Torres A, et al., 1999; Neiss and Reinecker, 2006). 
Within the MLNs, the bacterium successfully infects macrophages and triggering a response 
similar to that in epithelial cells to ensure its survival and replication (Alpuche-Aranda, 1994; 
Rydstrom and Wick, 2007). These infected macrophages then help in systemic dissemination 
of Salmonella via bloodstream to other tissues such as spleen and liver (Ohl and Miller, 2001; 
Worley et al., 2006).   
The Salmonella-Containing Vacuole (SCV) and intracellular survival 
Following internalization, Salmonella establishes itself within a membrane-bound vesicle 
termed as Salmonella-containing vacuole (SCV). This unique membrane-bound compartment 
serves as a replicative niche for the bacterium with in the cell (Garcia et al., 2008). The 
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biogenesis of the SCV is characterized by recruitment of several members of the Rab family 
of small GTPases (Smith et al., 2007), movement of the SCV from the plasma membrane to 
the perinuclear space (Ramsden et al., 2007), and interactions with host cell endocytic and 
exocytic pathways and involvement of Salmonella-encoded T3SS1 and T3SS2 effectors, 
which play a critical role in modulation and development of the SCV. 
Biogenesis of the SCV 
The biogenesis of the SCV has been divided into three stages: early (10min-1h post infection), 
intermediate (1h-4h), and late (>4h) {figure 2 and table 2} (García-del Portillo et al., 2008; 
Malik-Kale et al., 2011). Immediately after formation, the SCV undergoes rapid membrane 
modifications driven by the secreted T3SS1 effector’s SopB and SptP.  SopB acts through its 
phosphoinositide phosphatase activity to activate Akt via PI(3,4)P2 and PI(3,4,5)P3 (Steele-
Mortimer et al., 2000). SopB which recruits itself on cytosolic phase of SCV, reduces the 
levels of PI(4,5)P2 and phosphotidylserine resulting in reduced levels of negatively charged 
lipids on the SCV (Mallo et al., 2008). This leads to exclusion of several Rab’s and/or 
prevents the fusion of SCV with lysosomes (Bakowski et al., 2008). SopB also recruits 
GTPase Rab5 to the SCV membrane, leading to recruitment of the sorting nexins SNX1 and 
SNX3, important regulators of membrane trafficking. SNX1 is a member of a retromer sorting 
complex that mediates the retrieval of receptors from the endolysosomal pathway to the trans-
golgi network (Bujny et al., 2008; Braun et al., 2010). Within few minutes of Salmonella 
infection, SNX1 shifts from its endosomal localization to the site of bacterial entry. SNX1 
then results in formation of spacious tubules, reducing the vacuolar size and removing the 
cation-independent mannose-6 phosphate (CI-M6PR) receptor from the nascent SCV (Bujny 
et al., 2008). CI-M6PR is important for delivering soluble lysosomal enzymes to lysosomes 
and as it is normally excluded from SCV, therefore enabling the bacteria within SCV to 
survive and replicate (Garcia and Finlay, 1995). SNX3 on the other hand recruits Rab7 and 
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LAMP-1 to the SCV membrane and contributes towards the SCV movement to peri-nuclear 
region (Braun et al., 2010). 
 The intermediate stage in the SCV biogenesis is mainly characterized by involvement 
of dynein, as Salmonella uses dynein-mediated transport along the microtubules in order to 
reach a peri-nucelar position adjacent to the microtubule organizing center (MTOC) 
(Ramsden et al., 2007). This process is mediated by effector proteins both from T3SS1 (SipA 
and SopB) and T3SS2 (SifA, SseF and SseG) (Wasylnka et al., 2008). In addition, the actin-
based motor non-muscle myosin II, is also implicated in contributing to SCV positioning 
involving the phosphate activity of SopB (Wasylnka et al., 2008). During the late phase of 
SCV maturation, a set of T3SS effector proteins act in a co-operative manner in order to 
maintain the SCV at the peri-nuclear space, and also to initiate bacterial replication within the 
SCV (Abrahams et al., 2006; Deiwick et al., 2006). At the same time, from the cytosolic 
surface of the SCV membrane, tubules begin to extend rapidly along microtubules towards 
the cell periphery, accompanied by the acquisition of various late endosomal markers such as 
Lamps (LAMP-1 and LAMP-2), vATPases and Rab9 and Rab7 (Steele-Mortimer, 2008).  
 A T3SS2 effector protein, SifA, is required for formation of the prominent tubular 
structures known as Salmonella-induced filaments (Sifs; Stein et al., 1996). SifA, along with 
another T3SS2 effector, PipB2, leads to recruitment of two host cell proteins, kinesin-1 and 
kinesin binding protein protein SKIP (SifA and kinesin-interacting protein) on the SCV which 
play an important role in Sif formation and maturation of the SCV (Boucrot et al., 2005; 
Dumont et al., 2010). 
SseJ, a T3SS2 effector protein which shares homology to glycerophospholipid:cholesterol 
acyltransferaces ( GCATs; Lossi et al., 2008), is involved in SCV/Sif biogenesis and stability, 
as it leads to cholesterol esterification and lipid formation from the SCV, which are enriched 
in cholesterol (Nawabi et al., 2008). The function of these Salmonella induced tubules still 
remains unclear; however, one possibility is that Salmonella might use these for nutritional 
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requirements within the SCV by intercepting host cell trafficking pathways (Mota et al., 
2009). However, it remains unclear whether the tubule formation takes place in vivo.  
 
 
 
Figure 2. Biogenesis of the SCV.Upon attachment to the host cell surface Salmonella secreats numerous 
virulence effector proteins into the host cell cytoplasm using its T3SS needle complex. These effectors bring 
about modulation within host cell cytoskeleton thereby stimulating actin-mediated bacterial internalization by 
causing ruffling in the host cell membrane. The internalized bacterium develops a membrane vacuole around 
itself and resides within this compartment called the Salmonella-contaning vacuole (SCV). The SCV interacts 
with the host endocytic pathway and matures acquiring various host cell markers such as EEA, LAMP-1, and 
LAMP-2 etc. The bacterium replicates within the SCV and the SCV eventually develops into a tubular network 
called Salmonella-induced filaments (sifs). (Taken from Kale et al., 2011; under free license agreement). 
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Table 2. Stages of SCV biogenesis: Table summarizing stages of SCV biogenesis with their characteristics, host 
markers associated at each stage and T3SS effectors involved during the stages of SCV development and 
maturation. 
 
Escape from SCV 
The SCV is considered the primary survival and replicative niche for intracellular Salmonella; 
however, this may vary depending upon the host cell type where the bacteria can also be 
found in the cytosol.  Although SCV is a replicative niche in cultured epithelial cells and 
macrophages, but it is not the case in fibroblasts and dendritic cells (Garcia-del Portillo et al., 
2008). Recent studies have indicated that in epithelial cells Salmonella can exhibit a bimodal 
lifestyle, with replication within the SCV as well as in the cytosol (Malik-Kale et al., 2012). 
Interestingly, in the HeLa epithelial cell line, Salmonella shows robust growth in the host cell 
cytoplasm (Brumell et al., 2002; Knodler et al., 2010). This may not, however, be the case in 
macrophages where the cytosolic environment has been reported to be lethal for Salmonella 
(Malik-Kale et al., 2011).  
SCV stage Characteristics Hostcell 
markers 
T3SS effectors implicated 
Early 
(<30min) 
Simple vacuole or 
spacious phagosome. 
EEA1, rab5a, 
rab5b, rab5c, 
transferrin 
receptor 
T3SS1: SipA, SopA, SopB, 
SpiC/SsaB T3SS2: SpiC 
Intermediate 
(30 min – 4 
h) 
Vacuole primarily in 
juxtanuclear position 
Lamps, vATPase, 
rab7, rab11a, 
rab11b 
T3SS1: SopB, SipA  
T3SS2: SSeF, SseG, 
SpiC/SsaB, SteC, SseJ/SifC 
Late (>4 h) Initiation of intracellular 
replication and formation 
of tubules (Sifs) radiating 
throughoutcells. 
Microtubule and actin 
accumulation around 
juxtanuclear SCV. 
Lamps, vATPase, 
rab7, rab9 
T3SS2 PipB2, SifA, 
SopD2, SpiC/SsaB, SseF, 
SseG, SseJ/SifC, SteC, 
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 In addition, it has been reported that SCV membrane damage caused by the bacterial 
secretion systems, in particular T3SS2, could also lead to targeting of the bacterium for 
degradation via lysosomes through the host cell protein and organelle turnover system known 
as autophagy (xenophagy) (Birmingham et al., 2006). It has been reported that post-invasion, 
a fraction of bacteria (~ 20%), show damaged SCV membranes and are exposed to the 
cytosol, where the bacteria  are associated with ubiquitinated proteins (Birmingham et al., 
2006) and these ubiquitnated bacteria are then targeted to lysosomes which results in killing 
of bacteria (Perrin et al., 2004). S. Typhimurium may also induce autophagy in macrophages, 
possibly due to effects on mitochondrial membrane morphology by the T3SS1 effector SipB 
which localizes to mitochondria membrane (Hernandez et al., 2003).   
Autophagy 
Autophagy is the cellular process whereby lysosomes contribute to the degradation of 
intracellular compartments such as organelles, proteins and even pathogens (Mizushima et al., 
2008; Mizushima and Komatsu, 2011). Autophagy is an important house-keeping process for 
all cells as it enables the cell to maintain and balance its sources of energy under normal as 
well as in response towards nutrient stress conditions thus in a way maintaining the overall its 
cellular homeostasis (Glick et al., 2010). Autophagy is also involved in cellular quality 
control by removal of damaged intracellular components (Hara et al., 2006). Defects in the 
ability to perform this cellular process have been linked to protein conformation disorders, 
neurodegenerative disorders and myopathies (Wong and Cuervo, 2010). Additional functions 
that have been recently attributed to autophagy includes cell survival and response to stress 
(Wang and Levine, 2010), tissue differentiation (Mizushima and Levine, 2010), senescence 
and even anti-ageing (Wong and Cuervo, 2010), thus preventing from diseases such as cancer 
diabetes, liver diseases and auto-immune diseases (Glick et al., 2010; Yang et al., 2011; 
Gonzalez et al., 2011). Thus, autophagy is a central, important house-keeping cellular process 
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which functions not only to eliminate intracellular aggregates and damaged organelles but 
also against intracellular pathogens. 
 The different steps involved in this process include, cargo-recognition, sequestration 
from the cytosol, delivery to lysosomes, degradation by lysosomal enzymes and recycling of 
the essential components of the macromolecule degraded (Yang and Klinosky, 2010a). 
Autophagy has been distinguished into three different types based on how the cytosolic cargo 
is recognized and targeted to lysosomes for degradation. The three best characterized 
processes which degrade unwanted/ no longer needed proteins and maintain cellular quality 
control are macroautophagy, microautophagy and chaperone-mediated autophagy (CMA). 
Macroautophagy 
This type of autophagy, involves degradation of cargo proteins which are recognized in bulk 
in the cytosol. Here, the cargo protein to be degraded is enclosed within a double membrane 
vesicle called the autophagosome (Mizushima et al., 2001). Molecules such as p62 or NBR1 
bind to cargo proteins through ubiquitinated residues and to Atg8/LC3, which are an 
important component of the autophagosome membrane (Lamark et al., 2009). These 
autophagosomes then fuse with lysosomes which are rich in hydrolases and other enzymes 
required for complete degradation of the cargo. Basal levels of macroautophagy are present in 
all cell types and contribute towards the maintenance of cellular homeostasis (Hara et al., 
2006; Ruben et al., 2008).  
Microautophagy 
In microautophagy, the cargo protein or substrate directly fuses to the lysosomes and are 
degraded. This process is marked by development of invaginations of the lysosomal 
membrane containing the cargo, which then pinches off as vesicles into the lysosomal lumen 
(Ahlberg and Glaumann, 1985). Microautophagy activity can be detected in many cell types; 
however, it is not known whether this pathway can be further upregulated under specific 
conditions. 
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Chaperone-mediated autophagy (CMA) 
Chaperone-mediated autophagy is a selective type process which is responsible for 
degradation of cytosolic proteins bearing a penta-peptide KFERQ amino acid motif, which 
targets them to the lysosome for degradation (Dice, 1990).  Substrate proteins that contain the 
KFERQ targeting motif are recognized by a cytosolic chaperone, the heat-shock cognate 
protein of 70kDa, Hsc70/Hsc73, in a complex with other co-chaperones (Chiang et al., 1989; 
Kaushik and Cuervo, 2012; Cuervo and Wong, 2014). After binding, the chaperone mediates 
delivery of the substrate protein to the surface of the lysosome, where it binds to a receptor at 
the lysosomal membrane, the lysosome-associated membrane protein type 2A (LAMP-2A; 
Cuervo and Dice, 1996). Interaction of the substrate with LAMP-2A promotes the 
multimerization of this lysosomal membrane protein into a higher order complex required for 
translocation of substrates across the lysosomal membrane (Bandyopadhyay et al., 2008). A 
luminal form of Hsc70/Hsc73 residing in the lysosomal lumen (ly-Hsc73) assists in the 
translocation of the substrate in an ATP-dependent manner (Chiang et al., 1989. Upon 
translocation into the lumen, the substrate proteins are rapidly degraded (in 5-10 min) by a 
wide range of lysosomal proteases and other hydrolytic enzymes. Organelles and other large, 
protein complexes do not function as CMA substrates, as they have to be transported through 
the lysosomal membrane and LAMP-2A complex. 
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Figure 3. Proteolytic systems in mammalian cells: Substrate proteins are delivered to lysosomes from the 
extracellular media (heterophagy) or from inside the cell (autophagy). The best described heterophagic pathway 
is endocytosis. In mammalian cells three types of autophagy pathway have been described namely 
macroautophagy, microautophagy, and chaperone-mediated autophagy (CMA). In macroautophagy the target 
proteins are sequestered within a membrane bound vesicle which then fuses with lysosomes. In microautophagy, 
substrate proteins are internalized directly into the lysosomal membrane. In CMA, the selective substrate 
proteins are translocated into the lysosomes membrane by a chaperone Hsc73 where the target proteins enter into 
the lysosomes through a translocon formed by lysosomal receptor (LAMP-2A). (Taken from Vicente and 
Cuervo, 2007; Copyright permission licence 3405891134143). 
 
Substrates for CMA 
A basal level of CMA activity is detectable in almost all cell types, and approximately 30% of 
soluble cytosolic proteins contain the CMA targeting motif (Dice, 1990). Substrates targeted 
through this selective type of autophagy includes a heterogeneous pool of intracellular 
proteins including glycolytic enzymes such as GAPDH (glyceraldehyde-3-phosphate 
dehydrogenase), aldolase, phosphoglyceromutase, transcription factors and inhibitors of 
transcription factors (e.g. c-fos, inhibitor of NFκB (IκB)), vesicular trafficking proteins such 
as alpha-synuclein, calcium binding proteins (Annexin I, II, IV and VI), cytosolic forms of 
secretory proteins (alpha-2-microglobulin), as well as catalytic and subunits of proteasome, 
the major cytosolic protease (Massey et al., 2004). 
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Components of CMA 
Molecular chaperone complex: The heat shock cognate protein Hsc70, (also known as 
Hsc73) is a molecular chaperone which belongs to the heat shock protein 70 (Hsp70) family 
(Chiang et al., 1989; Panjwani et al., 1999). Due to the different nomenclature designations 
and isoforms, Hsc70 is hereafter referred to as Hsc73 throughout the thesis. Hsc73 is 
constitutively expressed and is responsible for protein translocation across membrane (Craig 
et al., 1994). The cytosolic form of Hsc73 recognizes proteins containing KFERQ motifs and 
thus selectively targets the substrate proteins to lysosomes for degradation (Craig et al., 
1994). A number of other co-chaperones interact with Hsc73 and regulate its activity. The 
heat shock protein Hsp40 stimulates the ATPase activity of Hsc73 and leads to enhanced 
binding and also release of substrate proteins. Hsc73 interacting protein (Hip) stimulates the 
assembly between Hsc73, Hsp40 and substrate proteins (Hohfeld et al., 1995; Suh et al., 
1999). Another important chaperone that plays an important is heat shock protein of 90 kDa, 
Hsp90. Hsp90 prevents the unfolded proteins from aggregating or refolding of substrate 
proteins (Richter and Buchner, 2006). The Hsp90-Hsc73 organizer protein (Hop) links Hsc73 
and Hsp90 (Demand et al., 1998). Hsc73 along the chaperone complex carries the target 
protein to the lysosomal membrane where the substrate protein binds to the lysosomal 
associated membrane protein 2A (LAMP-2A). 
LAMP-2A: The lysosome associated membrane protein-2A (LAMP-2A), belongs to the 
family of membaneglycoproteins similar to LAMP-1 (Sawada et al., 1993). LAMP-2A is one 
of the three splicied isoforms originated as result of alternative splicing of the lamp2 gene. 
The three isoforms LAMP-2A, LAMP-2B and LAMP-2C, differ from one another in the 
aminoacid sequence representing the C-terminus region (Cuervo and Dice, 2000). Lamp-2A is 
an integrated membrane protein which is present as single monomers in the lysosomal 
membrane with a single transmembrane region. The majority of the protein lies in 
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glycosylated into the lysosmal lumen and a short cytosolic tail present in the cytoplasm 
(Eskelinen et al., 2005). 
 Of the three isoforms, only LAMP-2A is known to have a function in the CMA 
process, as it acts like a receptor for the incoming substrate protein destined to be degraded 
via the CMA pathway (Cuervo and Dice, 1996). The chaperone Hsc73 carries the substrate 
protein bearing the pentapeptide sequence KFERQ to the lysosomal membrane, where the 
substrate protein binds to the cytosolic region of LAMP-2A (Bandyopadhyay et al., 2008). 
The binding of the substrate protein to LAMP-2A is the rate limiting step in the CMA 
pathway (Cuervo and Dice, 2000c), as this results in multimerization of LAMP-2A monomers 
to form a translocon through which the substrate protein passes into the lysosomal lumen and 
is eventually degraded (Bandyopadhyay et al., 2008). 
The lysosomal form of Hsc73 (lys-Hsc73): A lysosomal form of Hsc73 is also present into 
the lysosomal lumen (Agarraberes et al., 1997). Furthermore this lysosomal form of Hsc73 is 
stable at acidic conditions. Similar to the luminal chaperones present in mitochondria and ER 
which are required to pull proteins into these organelles, the Lys-Hsc73 is also believed for 
transport of the substrate proteins into the lysosomes which are then further degraded by 
lysosomal enzymes (Brodsky et al., 1998; Artigues et al., 2002), as CMA could be completely 
blocked by allowing fibroblast cells to endocytose an antibody specific for Hsc73 
(Agarraberes et al., 1997). 
Regulation of CMA 
CMA is activated maximally under stress conditions, such as oxidative stress, nutrient 
deprivation such as serum (and/or amino acid) deprivation and exposure to toxins (Wing et 
al., 1991; Cuervo et al., 1999; Kiffin et al., 2004). The selective nature of CMA is considered 
beneficial during prolonged starvation, as it favours the degradation of non-essential proteins 
thus providing amino acids for cell survival. Furthermore, under oxidative stress conditions it 
facilitates the selective removal of damaged proteins. 
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 LAMP-2A levels in the lysososmal membrane play an important role in regulating the 
functional activity of CMA (Cuervo and Dice, 2000b). Levels of LAMP-2A at the lysosomal 
membrane are tightly regulated as this membrane protein undergoes rapid cleavage by 
membrane metalloprotease and cathepsin A (Cuervo et al., 2003). LAMP-2A degradation 
decreases under conditions facilitating CMA activation (nutrient stress or oxidative stress) 
thereby resulting in a doubling of the half-life of LAMP-2A. However under low CMA 
activity, LAMP-2A is found in cholesterol rich domain within the lysosomal membrane. 
Upon treating mammalian cells with cholesterol extracting drugs such as methyl-
β−cyclodextrin results in increment of LAMP-2A levels in the lysosomal membrane, thus 
activating CMA (Kaushik et al., 2006). 
Pathological relevance of CMA 
Chaperone mediate autophagy is a selelctive form of autophagy where intracellular proteins 
containing a recognition motif are specifically selected and degraded in lysosomes (Dice, 
1990). Thus any malfunction or inability of a cell to perform CMA has been linked to the 
onset of sererval human disorders (Arias and Cuervo, 2011). 
 Impairments in CMA activity have been associated with several neurodegenerative 
diseases such as Alzheimer’s, Parkionson and Huntington’s diseases (Cuervo et al., 2004; 
Wang et al., 2010; Arias and Cuervo, 2011). With increasing age of an individual the CMA 
activitiy declines, due to reduction of LAMP-2A levels at the lysosomal membrane (Cuervo 
and Dice, 2000a) This age dependent dysfunction in CMA activity contributes to lysosomal 
storage disorders, different types of toxic neuropathies and diabetes (Cuervo et al., 1999; 
Sooparb et al., 2004; Venugopal et al., 2009; Welsch et al., 2010). 
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Figure 4. Schematic representation of CMA pathway. Substrate proteins bearing the KFERQ amino acid 
motif are recognized by heat shock cognate protein 73 kDa (Hsc73) in the cytosol, which then transfers the 
substrate protein in association with other co-chaperones to the cytosolic face of LAMP-2A on the lysosomal 
membrane. LAMP-2A multimerizes with binding of substrate protein and it acts as a trans-locon through which 
the substrate protein is delivered into the lysosomal lumen with the help of lysosomal Hsc73. Within the 
lysosome the substrate protein is degraded by hydrolytic enzymes and lysosomal proteases into amino acids to 
be re-used by the cell. An estimated 30% of total cell proteins are turned over via the CMA pathway (Cuervo and 
Wong (2014). (Figure modified with permission from Karsten Tedin, 2011 unpublished) 
 
Furthermore, upregulation in basal levels of CMA activity has been described for survival and 
proliferation of cancer cells due to upregulation of LAMP-2A levels in the lysosomal 
membrane (Saha, 2012; Cuervo and Wong, 2014). Thus both reduction and overexpression of 
CMA activity has been linked to various diseases signifying the importance of regulating the 
CMA activity at basal levels in all cell types. 
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AIMS 
Salmonella spp. are facultative, intracellular pathogens, which infect and proliferate within 
intestinal epithelial cells, macrophage and other cell types. Post-infection or -invasion of host 
cells, Salmonella remains within a membrane-bound intracellular compartment referred to as 
the Salmonella-containing vacuole (SCV) (Holden, 2002; Garcia-del Portillo et al., 2008; 
Steele-Mortimer, 2008; Bakowski et al., 2008; Eswarappa et al., 2010; Lahiri et al., 2010). 
Although establishment of the SCV has been well characterized, little is known about how 
Salmonella obtains nutrients and substrates required for growth within this compartment 
(Lundberg et al., 1999; Yimga et al., 2006; Bowden et al., 2010; Dandekar et al., 2012; 
Bowden et al., 2014). 
 Interestingly, over 90% of clinical isolates of Salmonella Typhi, the causative agent of 
human Typhoid, have been shown to be auxotrophic for amino acids (Virgilio and Cordano, 
1981). Furthermore, Hoiseth and Stocker (1981) showed that aroA strains of Salmonella 
Typhimurium are highly attenuated in mice models of infection. aroA strains are unable to 
synthesize chorismate, the precursor for aromatic amino biosynthesis (Neidhardt et al.1996; 
Eisenreich et al., 2010) However, these authors also showed that wild-type levels of virulence 
can be rescued by providing mice with metabolites not involved in aromatic amino acid 
biosynthesis but which also require chorismate. These studies suggest that in vivo, Salmonella 
must have have access to host-derived sources of amino acids for intracellular growth. We 
were therefore interested to know how Salmonella could acquire nutrients within the SCV in 
this situation.  
As Salmonella should be dependent upon host cell proteins and pathways for accessing 
sources of nutrients within the host, I therefore chose to examine more closely some of the 
host proteins present at the SCV membrane which might be involved in providing peptides, 
which could provide a source of both carbon sources as well as amino acids. 
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 Furthermore, for characterization of various host proteins and compartments which 
might interact with the SCV, it was necessary to purify Salmonella-containing vacuoles from 
infected host cells. In an effort to avoid chemical or physical interactions which could affect 
and possibly disrupt the labile SCV membrane, I therefore developed a relatively simple, 
rapid method to purify intact SCV’s using paramagnetic nanoparticles. 
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Methods 
Molecular biology methods 
Plasmid preparations from E. coli and Salmonella 
A single bacterial colony was inoculated into 5 ml L-broth (Lennox, 1955) containing the 
appropriate antibiotic and incubated at 37ºC with aeration until the cultures reached an optical 
density at 600 nm (OD600) of approximately 2. Plasmid DNA from bacterial cultures was 
isolated using the Qiagen Plasmid Midi Kit (Qiagen, Inc.) according to the manufacturer’s 
instructions. 
Precipitation of DNA 
Approximately one-tenth volume of 3M sodium acetate (pH 5.5) and 2.5 volumes of ice cold 
100% ethanol were added to the sample containing the DNA. The samples were mixed and 
were allowed to precipitate at -20°C overnight. The following day, the samples were 
centrifuged at 18500 rpm for 60 min. at 4°C. The resulting pellets were washed twice with 
70% ethanol, air-dried and re-suspended in sterile, deionised water. 
Determination of concentration of nucleic acids 
The concentrations of DNA were determined either by Spectrophotometer or Nanodrop 
Spectrophotometer (PeqLab) according to the manufacturer’s instructions. For quantification 
of the amount of DNA present, the following formula was used: 
1 unit of absorbance of dsDNA at 260 nm (A260) = 50 µg/ml dsDNA 
The purity of the DNA samples was determined by calculating the ratios of the absorbance at 
A260 to A280. DNA samples are considered adequately pure if 1.8 ≤ absorbance at A260 / 
absorbance at A280 ≤ 2.0. A value less than 1.8 indicates contamination with proteins or with 
aromatic substances like phenol, while a value greater than 2.0 indicates possible 
contamination with RNA. 
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Electrophoresis and detection of nucleic acids on agarose gels 
Agarose gel electrophoresis was used for the routine analysis of DNA. Depending upon the 
size of DNA fragment to be separated a 0.8- 1.2% agarose gels were casted using 1X Tris-
borate buffer (TBE) containing 0.5 µg/ml Midori Green Advance. DNA samples mixed 
thoroughly in DNA loading buffer were allowed to run in agarose gels at 100 V (generally, 
10V/cm).  
Polymerase chain reaction (PCR) 
Desired DNA fragments were amplified using the thermostable DNA polymerases. The DNA 
fragments up to 2kb were amplified using the standard BioTherm Taq polymerase 
(Rapidozym). The PCRs were set up and performed according to the following specifications. 
Table 3.  PCR reaction mixture pippeting Scheme 
 
Reagent Amount 
Forward primer (10 pmol/ µl) 
 
1 µl 
Reverse primer (10 pmol/ µl) 1 µl 
dNTP mix (2mM) 5 µl 
10X Reaction buffer 5 µl 
MgCl2 (50mM) 1.5 µl 
DNA template 10-100 ng 
HPLC water Up to 50 
DNA polymerase 1 unit 
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Table 4. PCR thermal cycling programme 
Phase Temperature and time 
Denaturation 94°C, 3 min 
94°C, 1 min 
45 – 60°C, 1min 
Denaturation 
Annealing                35 cycles 
Elongation 72°C, 1-2 min 
Extension 72°C, 10 min 
 
Large DNA fragments of size more than 2kb were amplified using Abgene Extensor Hi-
Fidelity PCR master mix (Thermo Scientific) according to the supplier’s instructions. 
Microbiological methods 
Preparation of bacterial stocks 
Bacterial laboratory stocks were streaked to Lennox agar with or without antibiotics and 
incubated overnight at 32°C or 37°C, depending on the strain. 5 ml of Lennox broth was 
inoculated with a single colony and grown until an OD600 of 2-3. 1 ml of this bacterial 
culture was transferred to a cryo-tube containing 300 µl of a sterile 80% glycerol solution, 
vigorously mixed and preserved at -80°C. 
Preparation of competent bacteria for transformation with plasmid (rapid method) 
A single bacterial colony was inoculated in 5 ml of LB containing appropriate antibiotic and 
grown on a shaker (200rpm) at either 30 or 37°C depending on the strain. Upon reaching an 
OD600 of 2-3, the bacterial culture was transferred to 1.5 ml Eppendorf tubes. The bacteria 
were pelleted by centrifugation at 13500rpm, 5 min and supernatant discarded. From this step 
onwards, the entire procedures were done on ice. The pellets from two tubes were 
resuspended in 1 ml of 10% ice cold glycerol and centrifugation was repeated with decreasing 
speeds of 6000x g, 3000x g, 2000x g and 1500x g for 5 min each at 4°C. The resuspended 
cells from two tubes were pooled prior to last round of centrifugation. The pellet was finally 
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resuspended in 400 µl of 10% glycerol and aliquots of 100 µl in pre-frozen 1.5 ml Eppendorf 
tubes were stored at -80°C. 
Electroporation 
Prior to electroporation, the electrocompetent cells were thawed on ice. 1-2 µl of the prepared 
DNA was added on to the thawed electrocompetent cells and the mix was transferred to a 2 
mm electroporation cuvette. Using the EasyjecT Prima (peqLab), the mix was pulsed at 2.5 
KV according to the standard protocol. The samples were immediately resuspended in 1 ml of 
LB without any antibiotics and incubated for 1 hour at room temperature. After this recovery 
period, transformants were selected by plating the diluted samples on selective medium. 
Generation of bacterial mutants 
All S. enterica serovar Typhimurium strains used in this study were derivative of the wild-
type strain SL1344 (Hoiseth and Stocker, 1981). Deletion mutants were first constructed by 
directed, non-polar gene deletion/replacement with a kanamycin-resistance cassette in strain 
S. enterica serovar Typhimurium LT2 according to the method of Datsenko and Wanner 
(2000). After verification of the chromosomal location of the kanamycin-resistance 
cassette/gene deletion by PCR amplification of the insertion site/antibiotic cassette, 
bacteriophage P22 lysates were prepared. The gene deletions were then transduced into the 
wild-type SL1344 strain by bacteriophage P22 transduction with selection for kanamycin 
resistance. Phage P22-free clones were selected as single colonies taken from Green plates 
onto which independent, kanamycin-resistant clones had been streaked from cultures grown 
in L-broth with selection for kanamycin resistance. A second PCR verification for the correct 
gene deletion/chromosomal flanking regions of the P22 transductants was performed prior to 
preparation of bacterial stocks. 
 Multiple deletions were constructed sequentially after elimination of the kanamycin-
resistance cassette by introduction of the FLP-recombinase expressing plasmid, pCP20 
(Cherepanov and Wackernagel, 1995). After screening for loss of the kanamycin-resistance, 
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plasmid pCP20 was eliminated by growth at 37°C. Subsequent deletions were introduced by 
bacteriophage P22 transduction as above. The list of mutant strains, are summarised in Table 
7. The sequences of all the primers used in this study are listed in Table 9. 
Preparation of bacteriophage P22 stocks 
After PCR verification of the deletion of chromosomal genes and replacement with the 
kanamycin-resistence cassette, it was necessary to transfer the gene deletion/replacement 
region into the virulent, isogenic strain used for further studies. The transfer of the genetic 
regions were performed by bacteriophage P22 generalised transduction using a derivative of 
P22, HT105/1, which harbours a mutation in the integrase gene and is unable to form 
lysogens, but remains capable of packaging both viral and chromosomal DNA (Schmieger 
and Buch, 1975). Donor bacteria were inoculated in 6 ml L-broth containing 10 mM MgSO4 
and 5 mM CaCl2 and grown to OD600 approx. 2 at 37ºC. 5 to 10 µl of bacterial culture was 
transferred to a pre-warmed sterile test tube containing 6 ml of 0.7% soft agar, 10 mM 
MgSO4 and 5 mM CaCl2 and maintained at 70ºC before adding bacterial culture. The 
mixture containing soft agar and bacteria was poured onto a LB agar plates and ket at room 
temperature for 10 minutes in order to allow hardening of the soft agar. P22 particles (100 µl) 
were spotted onto the soft agar and allowed to soak into the plates containing bacteria.Once 
the phage mixture has dried; the plates were incubated overnight at 37ºC. The following day, 
cleared zones on the soft agar plates were collected using a sterile spatula and transferred to a 
15 ml polypropylene tube (Falcon). 1 ml L-broth containing 10 mM MgSO4 and 5 mM CaCl2 
and 1 µl of chloroform were added in to polypropylene tube and incubated overnight at 4ºC to 
allow diffusion of the bacteriophage out of the agar. The following day, the tubes were 
centrifuged at 7,500 rpm 15 minutes at 4ºC to remove the agar and cell debris. The clear 
supernatants were transferred to eppendorf tubes and stored at 4ºC for further usage. 10 µl of 
Methods 
 
34 
 
chloroform/ml supernatant was added into each phage stock to prevent bacterial growth and 
maintain sterile stocks of bacteriophage. 
Transduction of Salmonella with phage P22 
The recipient bacterial strain was cultured to OD600 approx. 2 in 6 ml L-broth containing 10 
mM MgSO4 and 5 mM CaCl2 at 37ºC. 2 to 5 µl of the donor P22 phage lysate was further 
added to 100 µl of the bacterial culture and incubated at 37ºC for 20 minutes. EGTA was 
added with a final concentration of 20 mM to chelate the metal ions necessary for phage 
infection to stop the reaction. The volume of the mixture was brought to 1 ml with L-broth 
containing 20 mM EGTA and 100 µl aliquots of the mixture was plated onto L-broth agar 
plate containing the appropriate antibiotic. Transductants were further screened on Green 
plates for the absence of lysogens and infecting phage (Sternberg and Maurer, 1991). Infected 
bacterial colonies due to lysis of bacterial cells are indicated by a pH change as seen by a 
change in the media to dark blue/green, whereas uninfected colonies maintain a pale green 
color.  
Growth curves and growth on plates 
Bacteria were routinely grown in L-broth or M9 defined glucose minimal medium containing 
50 µg ml-1 histidine. Where indicated, M9 minimal medium was supplemented with 
phenylalanine at 50 µg ml-1, casamino acids at 1% (w/v), or heat-inactivated foetal calf serum 
at 10% (v/v). Dialysed casamino acids were prepared by dialysis of a 20% (w/v) solution of 
casamino acids in dialysis tubing (Serva Membra-Cell MWCO 3500, Heidelberg) against 
sterile, distilled water. Where used for selection of strains or plasmids, carbenicillin was 
present in the media at 100 µg ml-1, chloramphenicol at 15 µg ml-1, kanamycin at 50 µg ml-
1, and tetracycline at 20 µg ml-1. For generation of growth curves, strains were inoculated at 
105 cfu in 0.1 ml medium into replicate wells of a 96-well plate and growth was monitored by 
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determination of the optical density at 600 nm at 15 min. intervals over 24 h during incubation 
with shaking at 37°C on a heated Synergy HT microtiter plate reader (BioTek). 
Cell culture methods 
Maintenance and cultivation of eukaryotic cell lines 
Epithelial cell lines were maintained in DMEM/Ham’s F-12 salts (1:1) cell culture medium 
with heat inactivated fetal bovine serum (FBS) at 10% (v/v). Human (THP-1) macrophage 
cell lines were maintained in Iscove´s Modified Dulbecco´s Medium (Iscove´s/IMDM) 
supplemented with 10% FBS. All cell lines were incubated at 37°C with 5% CO2 with the 
cell culture medium replaced each two to three days. Confluent cell culture monolayers were 
passaged by detachment with trypsin/EDTA treatment. On the day of passage, the cell culture 
medium was removed and the cells were washed once with phosphate buffered saline (PBS; 
Biochrom). The PBS was removed and replaced with one culture volume of trypsin/EDTA 
(0,5%/0,2% w/v in PBS) and incubated 5 to 10 minutes at 37°C. The detached cells were 
transferred to a sterile, 15 ml centrifuge tube and the cell suspensions diluted 1:1 with cell 
culture medium containing FBS. The cells were collected by centrifugation in a swinging 
bucket rotor (Sigma 3K30) at 155 x g for 5 min. at 25°C. The supernatants were removed by 
aspiration, and the resulting cell pellets were resuspended in fresh medium at the original cell 
culture medium volume. Flasks or well plates were seeded at empirically determined dilutions 
depending on the cell line and the desired cell concentrations for maintenance (passage) or 
experimental cultures. The cells lines were maintained for up to ten passages, then replaced 
by fresh cell cultures from liquid nitrogen stocks. 
Cryopreservation of eukaryotic cell lines 
Stocks of each cell line were preserved in liquid nitrogen in the appropriate cell culture 
medium supplemented with 10% dimethylsulfoxide (DMSO). At passage, 1 ml of the cell 
pellet re-suspensions in cell culture medium was added to 0.1 ml of DMSO, mixed gently, 
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and placed immediately to ice. The cryogenic vials with the cells were first stored one to three 
days at -80°C and then transferred to liquid nitrogen for long-term storage. 
Gentamicin protection/invasion assays 
The gentamicin protection assay or invasion assay is frequently used to study eukaryotic cell-
pathogen interaction as an infection model (Shaw and Falkow, 1988; Elsinghorst, 1994; 
Edwards and Massey, 2011). Briefly, the respective cell line was seeded into 24-well plates 
with 1 ml of the appropriate cell culture medium. The cells were incubated at 37℃ in 5% CO2 
until a confluent cell culture monolayer was achieved, approximately 2 x 105 cells per well in 
the 24-well plate format One hour prior to infection the cell culture medium was replaced 
with fresh medium. 
 The day before the invasion assay, bacterial strains were streaked from the frozen -
80°C stocks to a Lennox agar plate and incubated overnight at 37°C. The following day, 
single colonies were inoculated into L-broth and incubated at 37°C with shaking until the 
bacterial culture had reached the late log growth phase, corresponding to an optical density at 
600 nm (OD600) of approximately 2-3. One ml of this bacterial culture was centrifuged and 
the resulting cell pellet was suspended in 1 ml of cell culture medium. A 1:10 dilution of the 
resuspension was made and the OD600 was again determined and the initial bacterial counts 
per ml of suspension were calculated according to the assumption that an OD600 of 1 
corresponds to approximately 1 x 109 Salmonella cfu/ml. From this resuspension, the bacteria 
were diluted in cell culture medium to a concentration of approximately 106 cfu/ ml, and 100 
µl of this stock was used to inoculate each well of a 24-well plate containing approximately 2 
x 105 eukaryotic cells to yield a ratio of bacteria:eukaryotic cells (multiplicity of infection, 
MOI) of ≤ 1. Appropriate dilutions of the bacterial culture used for the infections were also 
plated onto L-broth agar to calculate the actual number of colony forming units used to infect 
the eukaryotic cells. 
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 Immediately after infection, the cell culture plates were centrifuged at 250 x g for 10 
minutes at room temperature to initiate infection (synchronization of infection). The plates 
harboring the infected cells were incubated for 60 min. at 37°C in 5% CO2 to allow the 
bacteria to penetrate the cells. 60 min. post-infection, 50 µg/ml gentamycin was added to the 
plates for an additional 60 min. to kill all remaining extracellular bacteria that had not 
penetrated the host cells. After one hour of co-incubation in the presence of 50 µg/ml 
gentamycin (2 h post-infection), the medium was replaced by fresh medium containing 10 
µg/ml gentamicin. At 2, 4, and 24 hours post-infection, cells were washed with 1X PBS and 
lysed by addition of 0.5 ml of 0.1% Triton X-100 in deionized, distilled water. Various 
dilutions of the resulting cell lysates were plated directly onto L-broth agar plates and colony 
forming units (cfu) were counted after overnight incubation at 37°C. The percentage of 
bacteria that were able to invade the eukaryotic cells was calculated as the ratio of cfu at 2 
hours post infection relative to the actual cfu used to infect the cells. The intracellular 
replication was determined using the ratio of cfu at 24 hours post infection and cfu at 2 hours 
post infection. The assays were repeated at least three times for each strain and each cell line. 
Invasion assays with inhibitors 
Epithelial cells (HEK293T and LoVo) were pre-treated with the various inhibitors at the 
indicated concentrations in cell culture media 4 h prior to infection. The inhibitor was 
maintained throughout the course of the assay. In these assays, cells were infected with the 
indicated Salmonella strains at a MOI of approximately 5 into 24-well cell culture plates 
(Corning). 30 min. post-infection, cells were washed with fresh medium containing 10% FCS, 
and were incubated in cell culture medium containing 50 µg/ml gentamycin (Sigma) and the 
specific inhibitor. After 1 h of incubation, cells were washed with pre-warmed 1X PBS and 
were incubated into cell culture medium containing 10 µg/ml gentamycin plus the same 
specific inhibitor for the remainder of the experiment. At the indicated time points post 
infection, the cell were dissolved/lysed using freshly prepared 0.1% triton X-100 (Sigma-
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Aldrich) in water followed by plating of released content on L-broth agar plates containing 
appropriate antibiotics to determine the intracellular cfu The ratio of cfu at 4 h relative to the 
actual input cfu was used to determine the percentage of invasive bacteria. 
Table 5. List of chemical inhibitors used to block various host cellular pathways 
Compound Source Working conc. Description 
3-methyl-adenine 
(3-MA) 
Sigma-aldrich 10 mM Macroautophagy 
inhibitor 
cyclohexamide 
(CHX) 
Sigma-aldrich 200 µg/ml CMA inhibitor 
ammonium chloride 
(NH4Cl) 
Sigma-aldrich 10 mM Prevents acidification 
of lysosomes 
Anti-Hsc73 
antibody 
13D3 (abcam) 10 µg/ml Inhibits CMA by 
blocking the activity 
of Hsc73. 
  
Cell Transfections 
The short-hairpin RNA (shRNA) plasmids against LAMP-1, LAMP-2A and negative control 
scrambled RNA constructs were purchased from S.A. Biosciences/Qiagen. Stable 
transfections of HEK293T cells with shRNA plasmids (300 ng/100 µl) targeting LAMP-1 or 
LAMP-2A was performed using HiPerFect transfecting reagent according to the manufacturer 
instructions (Qiagen, Cat. No. 301702) with cells grown in 24-well cell culture plates. Stably 
transfected cells were selected by adding puromycin (5 µg/ml) into the cell culture media after 
2 days of transfection. The reduced expression of LAMP-1 and LAMP-2A was confirmed by 
Western blotting of whole cell lysates of transfected cells. The confirmation by Western 
blotting was performed immediately after puromycin selection and was also repeated before 
cryopreserving the selected cells for storage. Selected cells were maintained in cell culture 
medium containing puromycin, and where subsequently passaged till passage number 5, 
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thereafter the stable cell line were either cryopreserved in liquid nitrogen or used for 
experimental purposes.  
b) Plasmids pCDNA 3.1-KFERQ-DsRed sequence and pCMV-GAPDH-HT were stably 
transfected into HEK293T cells using HiPerFect transfecting reagent as above. HEK293T 
cells were seeded into a 24 well cell tissue culture plates onto 12cm2 sterile coverslips (Roth). 
Mixture containing plasmid and transfecting reagent were added onto cells the same day in 
presence of serum free medium. The cells were incubated at 37°C, 5% CO2for 3 days in cell 
culture medium with neomycin (5µg/ml) selection. Stable transfections were confirmed by 
visualizing the cells under fluorescence microscopy as red fluorescent cells.  The transfection 
efficiency was estimated by comparing fields under phase contrast and red fluorescence 
emission wavelengths. Selected cells were maintained in Cell culture medium containing 
neomycin, and where subsequently passaged till passage number 5, thereafter the stable cell 
line were either cryopreserved in liquid nitrogen or used for experimental purpose. 
Salmonella-Containing Vacuole (SCV) Purification 
Overview of the method 
The method used for isolation of pathogen-containing phagosomes is rapid, easy and gentle so 
as to isolate Salmonella-Containing vacuoles (SCV) with intact membranes. The first step in 
the process employs labelling of bacteria with paramagnetic nanoparticles. This was achieved 
by co-incubating bacteria with carboxyl-coated nanoparticles. The labelled bacteria were then 
collected onto a 0.2 µm sterile filter to remove unbound particles which passed through the 
filter. After a wash, the filter was inverted and bacteria were recovered by backwashing with 
1X PBS. These labelled bacteria were then used to infect cells. 
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Figure 5. Schematic representation for the isolation of bacteria containing phagosomes. 1) Bacteria are 
made magnetic by incubating Salmonella with carboxyl coated paramagnetic nanoparticles. 2) These labelled 
bacteria are used to infect macrophages in a synchronized manner under centrifugation. 3) The host cells are 
lysed after 24hrs p.i. using a lysis buffer (0.1% Triton X-100 in ddH2O). 4) In presence of an external magnetic 
field the pre-labelled bacteria within the phagosome is collected. The collected cell lysate is then subjected for 
analysis in order to check the phagosome membrane integrity by microscopy 5) or proteomic analysis using 
Western blotting 6). (Adapted from Lonnbro et al., 2008; under free liscense agreement). 
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After a desired time point post-infection, the THP-1 cells were lysed using a lysis buffer 
which caused disruption of the host cells but without affecting the intracellular Salmonella. 
Application of an external magnetic field was used to collect the pre-labelled bacteria. The 
collected cell lysates were washed and subjected for further analysis either by confocal 
microscopy or Western-blotting as described in detail in the following section. 
Labeling of Salmonella with magnetic nanoparticles 
From a stock solution of 3 mg/ml of carboxyl-coated, paramagnetic cobalt nanoparticles of 
diameter 10 - 50 nm (TurboBeads, Zurich), a 0.5 ml aliquot was sonicated to disperse 
aggregates, followed by centrifugation at 1000 x g for 30s. Following centrifugation, 0.1 ml 
of the resulting supernatant was diluted 1:10 in sterile, deionized water prior to use. 
Salmonella strains grown in L-broth as described above were collected from 1 ml of culture 
by centrifugation in a microfuge at 16,000 x g for 5 min. The resulting bacterial pellets were 
resuspended in PBS and incubated in the presence of a 5:1 ratio of nanoparticles: bacteria at 
37°C for 20 min. with shaking. The bacterial suspension was then filtered through a 0.2 µm 
filter fitted to a 5 ml syringe. The filters were washed twice with two volumes of PBS, then 
the filter was inverted and the bacteria recovered in 1 ml of PBS collected into a sterile 
microfuge tube. This was then used either for infection or processed for Electron microscopy. 
Infection and purification of SCV 
THP-1 human macrophage cells grown in a 6-well cell culture plate were infected at a cell 
density of 106 cells/well with the nanoparticle-labelled Salmonella (MOI = 5) and incubated 
at 37°C, 5% CO2. 24 h post-infection, the cell culture media was removed, infected cells were 
washed twice with PBS then lysed by addition of 1 ml/well of cell lysis buffer (0.1% Triton 
X-100 in water). The resulting cell lysates were then placed in a magnetic field (Single Place 
Magnetic Stand, Ambion, USA) and the supernatant was carefully removed and discarded, 
and replaced by 1 ml of a 1X PBS/2% sucrose solution. The buffer was again removed and 
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replaced by 0.1 ml of the same buffer to concentrate the SCVs, which were then used either 
for staining with antibodies or subjected to SDS PAGE and Western blotting. 
Microscopy methods 
Co-localization studies  
Cells were grown to a confluency of about 75% in 24-well plates containing sterile, 12 mm 
diameter glass cover slips. These were then infected at an MOI of 5 with wild-type S. 
Typhimurium strain SL1344 or other Salmonella serovars harboring plasmid pGP704gfp 
(Vazquez-Torres et al. 1999). At the times indicated post-infection, cells were washed with 
pre-warmed 1X PBS and fixed in 4% paraformaldehyde in PBS for 15 min at 4°C. Fixed cells 
were washed twice with 1X PBS and permeabilised with 0.1% Triton X-100 in PBS for 5 
min.at room temperature, and again washed three times with 1X PBS. The infected cells were 
then blocked with 1.5% BSA in PBS for 1 h at room temperature under shaking conditions. 
The cells were then incubated with primary antibodies in blocking solution for either 1 h or 
overnight at 4°C. Cells were then washed twice with 1X PBS and incubated with the 
appropriate fluorescently-conjugated secondary antibodies for 1 h at room temperature. 
Coverslips were washed three times with 1X PBS and mounted inverted using Mowiol 
(Sigma) on glass slides and visualized using a Leica SP-2 laser confocal scanning microscope 
(LCSM) using a 63X oil immersion objective. All primary and conjugated secondary 
antibodies used are listed in Table 11 and Table 12. 
Co-localization with CMA substrate (GAPDH) and KFERQ targeting sequence 
HEK293T cells stably transfected with the pCMV-GAPDH-HT plasmid were seeded in 24 
well cell culture plates containing sterile coverslips at a cell density of 2x105 cell/well. Cells 
were incubated with culture medium containing 500 nM TMR-HT ligand (Promega) at 37°C, 
4 hrs prior to infection with Salmonella. 24 h post-infection, cells were fixed with 4% 
paraformaldehyde in PBS. The fixed cells were mounted with Mowiol and observed using 
confocal microscopy (LCSM Leica SP-2). 
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 HEK293T cells stably transfected with the plasmid pcDNA3.1-KFERQ-DsRed2 were 
seeded onto sterile coverslips, infected with GFP-expressing S. Typhimurium strains at an 
MOI of 5. 24 h post-infection, the infected cells were fixed using 4% PFA, washed, and 
incubated with 1.5% BSA in 1X PBS containing DAPI (1:500) for 1 hr at room temperature. 
After three washes with 1X PBS, the coverslips were mounted onto glass slides using 
Mowiol. These were visualized using confocal microscopy (LCSM Leica SP-2). 
Microscopic analysis for purified SCV’s 
Isolated SCV’s were incubated for 1 hr with specific primary antibody as mentioned in 1.5ml 
centrifuge tubes (Eppendorf) and placed in a magnetic stand. The solution opposite to the 
magnetic stand face was removed and the SCV’s were gently washed with 1X PBS/2% 
Sucrose solution, followed by incubation with the appropriate secondary antibody in the same 
tube for 1 hr. These were then again washed and mounted onto glass slides for visualization 
using confocal microscopy (LCSM Leica SP-2). 
Transmission electron microscopy (TEM) 
THP-1 cells were infected for 20-24 h with either labelled or non-labelled Salmonella, and 
then fixed by addition of fixative solution (1.5% PFA and 1.5% glutaraldehyde in 0.15 M 
sodium cacodylate buffer, pH 7.4). The fixed cells were incubated at RT for 1 h and were 
subsequently post-fixed for 2 h at 4°C in 1% osmium tetroxide in sodium cacodylate buffer, 
and dehydrated in a series of ethanol steps, and further processed with acetone for Epon 
embedding. Sections were cut with a microtome and mounted on Formvar coated copper 
grids. The sections were post-fixed with uranyl-acetate and lead citrate and examined under 
the electron microscope.  
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
Analytical polyacrylamide gel electrophoresis in sodium dodecyl sulphate was performed as 
described by Laemmli (1970). Samples were heated for 5 min at 100°C in protein loading 
buffer and volumes of 5-10 µl were loaded onto a 10% SDS-polyacrylamide gel cast in a 
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Ambersham multi-gel apparatus. Electrophoresis was performed at 33 mA. Once the 
bromophenol blue dye front reached towards the end of the gel, the electrophoresis was 
stopped. 
Western Blotting 
Purified SCV’s. Isolated SCV’s were collected by centrifugation, followed by resuspension 
in X ml of Laemmli (6X) buffer and boiling. Equal volumes were loaded onto a 12% SDS 
polyacrylamide gel and electrophoresed as described above. Post-electrophoresis, the proteins 
were transferred to nitrocellulose membrane (GE Healthcare) using a submarine blotting 
method. The resulting membranes were blocked by incubation in a solution of 3% skim milk 
powder in 1X TBS with shaking for 1hr. The blocked membranes were washed three times 
using 1X TBST (Tris Buffered Saline with 0.1% Tween-20) for 5 mins each. The membrane 
was then incubated with the appropriate primary antibodies diluted in blocking buffer at 4°C 
overnight with shaking. The following day, the membranes were washed with 1X TBST and 
incubated with HRP-conjugated secondary antibodies for 1 hr. Signals were revealed using 
ECL detection system kit (ThermoScientific Pierce).  
LAMP-2A and LAMP-1 knockdown cell lines. HEK293T cells, transfected with either anti-
LAMP-2A or anti-LAMP-1 shRNA plasmids or scrambled RNA control plasmid were lysed 
with 0.1% TritonX-100 in milliQ water. The cell lysates were collected using centrifugation 
and were heated in Laemmli buffer for 5 mins at 90°C. These were then loaded onto SDS gels 
as described above and processed for Western Blotting as described for SCV preparations 
above. The knock-down of gene expression was confirmed by Western blotting using specific 
antibodies and developing the membrane using HRP-conjugated secondary antibodies using 
the ECL detection kit, as described above. 
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Statistical Analysis and Software 
Statistics 
1. Microscopic images in the results section are a representative images of at least 25 
images per condition performed in duplicates from at least three independent 
experiments. 
2. The graphs representing intracellular growth ,inhibitor assays and invasion rates are a 
result of data derived from at least three independent experiments and represent 
mean+- std with statistical significance addressed with Mann-Whitney U-test (ns=non-
significant :p > 0.05, **: p< 0.01, ***: p< 0.001) as performed with Graphpad prism 
statistical software. 
3. The western blotting images representative cropped images from the original full 
length developed membranes of at least three independent experiments and arranged 
in one panel for better characterization. 
4. For quantification of microscopic images, at least 25 images per condition in 
duplicates from at least three independent experiments were counted to plot the 
graphical representation of the data. 
Software 
1. GraphPad Prism and SigmaPlot: GraphPad Prism version5 was used for preparing 
all the graphs and statistical analysis of the data as indicated in the figures legends. 
The graphs representing the growth curves of wild type Salmonella strain and the 
peptide dependent mutant strain were prepared using the SigmaPlot 11.0 Statistical 
software  
2. Image J (http://rsb.info.nih.gov/ij/index.html) : Western blot gels were quantified 
using Image J software. The graphs are a representative of 3 individual experiments 
pooled together as arbitrary values of Intensities.	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3. Paintshop Pro and AdobePhotoshop: Images representing growth on plates were 
assembled together in one panel for better characterization and representation using 
the Paint Shop Pro Software. All the other modifications (labelling, arrow heads etc) 
in the images were performed using the AdobePhotoshop 7.0.1 software.	  
4. PlagScan: (http://www.plagscan.com). Plagarisim scan was performed using the 
PlagScan online Software. The report generated is as follows:-	  
“116 matches from 14 sources, of which 14 are online sources. Plagiarism level: 
   4,5%  Results of plagiarism analysis (excluding references section) from 2014-08-01 
06:36 UTC” 
A detailed documented report is deposited as both .pdf and Microsoft Word versions 
at the Institute for Microbiology and Epizootics, Freie Universität Berlin with Dr. 
Karsten Tedin.	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Results 
The primary pre-requisite for any intracellular pathogen in order to grow and replicate 
successfully with-in its host is to evolve specific mechanisms to access nutrients with-in its 
host. Furthermore, modulations in nutrient availability, in particular of ‘Carbon’ source with-
in the host has been reported to influence and regulate the expression of various virulence 
genes and factors of the pathogen (Poncet at al., 2009; Bouguenec and Schouler, 2011). 
Hence a deeper understanding about the accessibility of nutrients from the host for bacterial 
replication and survival is important for greater understanding of host-pathogen interactions 
as it would serve as a potential landmark in development of therapeutic strategies against the 
pathogen without affecting the host. 
I. Growth analysis of Salmonella wild-type and peptide-dependent mutant strains 
After infection of host cells, Salmonella Typhimurium resides within a membrane-bound 
compartment within the host cells known as the Salmonella-containing vacuole (SCV). This 
intracellular compartment has been suggested to be limiting for nutrients (Appelberg, 2006; 
Dandekar et al., 2012). Despite these presumably poor growth conditions, Salmonella 
survives and replicates within this isolated compartment, indicating that the bacterium has 
access to intracellular or possibly extracellular sources of nutrients (Rajashkar et al., 2008; 
Garcia-del Portillo et al., 2008; Schroeder et al., 2011.). Recently, a number of studies have 
also shown the importance of sugar utilization pathways as well as other metabolic and 
catabolic pathways involved in intracellular growth of Salmonella (Yimga et al., 2006; 
Eisenreich et al., 2010; Bowden et al., 2010; Fuch et al., 2012; Hofreuter et al., 2012; Steeb et 
al., 2013; Bowden et al., 2014).  
However, as noted in the Introduction, clinical isolates of S. Typhi are nearly always amino 
acid auxotrophs, and the loss of virulence due to the lack of chorismate in S. Typhimurium 
aroA mutants, is regained when the folate deficiency is alleviated, indicating that the bacteria 
obtain aromatic amino acids within the host (Hoiseth and Stocker, 1981; Hölzer and Hensel 
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2012). These prior studies suggest that intracellular Salmonella obtain at least amino acids in 
some form or another from the host. 
 Recent studies in our laboratory have shown that in cell culture models of infection, 
the lack of either sugars (glucose and/or myo-inositol) or amino acids, or both, do not affect 
the intracellular growth of a wild-type strain of Salmonella Typhimurium. As shown in Fig. 6. 
the intracellular growth of wild-type Salmonella Typhimurium is not effected both in human 
epithelial (Fig. 6 a) cells and in human macrophages (Fig. 6 b) even after starving both the 
cell lines for over 20 hrs with the specific nutrients. These results imply that intracellular 
Salmonella have access to an alternative source of carbon units other than the sugars normally 
present in cell culture media. We were therefore interested in determining the possible sources 
of these nutrients to the bacteria residing within the SCV. 
a)       b) 
                                                                                   
Fig. 6. Intracellular growth of wild-type Salmonella Typhimurium under different nutrient conditions. 
Shown is the intracellular fold increase of the wild-type Salmonella at 24 h post infection in (a) LoVo human 
intestinal epithelial cells and (b) human macrophages when the cells are deprived for the indicated nutrients 24 h 
prior to infection. The data shown are the means and standard deviations of three, independent assays, where p > 
0.05 is considered non-significant (n.s.), *, p < 0.05; as determined with Mann-Whitney U-test. 
 
  
Salmonella acquires amino acids through multiple pathways which include de novo 
biosynthesis, uptake of free amino acids thorough the various amino acid transporters present 
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in the membrane of Salmonella, or through the uptake and catabolism of small peptides. 
Notably, amino acids (and peptides) also serve as carbon sources (reviewed in McFall and 
Newman, 1996). Indeed, one of the most frequently used bacterial growth media for 
Escherichia coli and Salmonella Typhimurium is Luria-Bertani or LB medium, which 
contains no fermentable sugars which can be used as carbon sources for these Gram-negative 
bacteria (Sezonov et al., 2007). As the intracellular growth of S. Typhimurium showed no 
obvious defects in the absence of either sugars or free amino acids (Fig. 6), we therefore 
considered the possibility that intracellular growth may, at least in part, be dependent upon 
access to host-derived peptides. 
 As noted above, prototrophic Salmonella are able to synthesise or take up free amino 
acids. In order to determine a role for host-derived peptides in intracellular growth, we 
constructed a mutant of Salmonella which is defective in both the uptake of the free aromatic 
amino acids (phenylalanine, tryptophan and tyrosine) and de novo biosynthesis of 
phenylalanine. Deletion of the genes encoding the transport systems involved in uptake of 
aromatic amino acids (ΔaroP, ΔpheP, ΔtyrP and Δmtr) and biosynthesis of phenylalanine 
(ΔpheA), confers a strict dependence upon peptides as the only source of phenylalanine for 
growth. 
 As shown in Fig. 7, the mutant strain (7752) shows growth similar to that of the wild-
type in growth medium containing amino acids in the form of oligopeptides such as L-broth 
or defined M9 minimal glucose medium containing casamino acids. However, the mutant 
does not show growth in either defined M9 minimal glucose medium containing 
phenylalanine, 1% bovine serum, or cell culture medium containing the full complement of 
amino acids and 10% bovine serum. These results verify that the mutant strain is not capable 
of biosynthesis or uptake of phenylalanine and further indicates that proteins present in bovine 
serum do not serve as a source of peptides to support its growth. Salmonella does not express 
extracellular proteases, thus it is unable to degrade large proteins, explaining the lack of 
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growth in the presence of inactivated bovine serum. Furthermore, like E. coli, Salmonella 
cannot transport peptides larger than 5 to 6 amino acids in length into the bacterial cytosol  
 
Fig. 7. Growth characteristics on solid media. Shown are the growth patterns of the strains indicated at the top 
of the column on the media indicated to the right: L-broth; M9 minimal medium supplemented with 0.2% 
casamino acids; M9 with 0.2% dialysed casamino acids; M9 with 50 µg/ml phenylalanine; M9 with 1% fetal calf 
serum (FCS); and DMEM/Ham´s F12 cell culture medium agar with 10% FCS. All M9 minimal basal media 
contain glucose and 50 µg/ml histidine to satisfy the histidine auxotrophy of strain SL1344. Strains: 7750 - 
SL1344 ΔaroP ΔpheP ΔtyrP Δmtr ΔpheA(pACYC184); 7752 -SL1344 ΔaroP ΔpheP ΔtyrP Δmtr 
ΔpheA(pMHEtetCDH); 7762 - SL1344(pACYC184); 7764 - SL1344(pMHEtetCDH). 
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through any of the known peptide uptake systems (Payne and Smith, 1994). Consistent with 
this, we compared the growth of both wild-type and the peptide-dependent mutant in defined 
M9 minimal glucose medium containing casamino acids which had been dialysed in order to 
remove peptides smaller than 3.5 kDa. As seen in Fig. 8, the mutant does not grow when 
supplemented with dialyzed casamino acids/peptides, indicating a strict dependence on small 
peptides as a source for nutrition to sustain growth. 
 
Fig. 8. Growth characteristics of the Salmonella ΔaroP ΔpheP Δ tyrP Δmtr ΔpheA mutant strain. Shown are 
the growth characteristics of the wild-type (panel A, strain 7764) or mutant strains (panel B, strain 7752) grown 
in M9 glucose minimal medium broth supplemented with 1% casamino acids (blue), 1% casamino acids 
dialyzed to remove peptides < 3.5 kDa (green), or cell culture medium containing the full complement of amino 
acids and 10% serum (red). The results shown are representative of duplicate, independent trials. 
 
In addition to determination of growth on agar-based media, we also examined growth of the 
wild-type and peptide-dependent mutant strains in liquid, broth cultures. As shown in Fig. 8, 
consistent with the plate tests, the mutant strain showed no growth in defined M9 minimal 
glucose media containing dialysed casamino acids nor in cell culture media with the full 
complement of amino acids and 10% inactivated bovine serum. Growth in the same glucose 
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minimal medium base containing complete (non-dialysed) casamino acids showed growth 
similar to the wild-type strain. As shown in Fig. 7 and 8, the wild-type strain of Salmonella 
showed growth under all conditions tested. These results verified that the Salmonella ΔaroP 
ΔpheP ΔtyrP Δmtr ΔpheA mutant strain was strictly dependent upon small peptides for 
growth as a source of phenylalanine, both in the presence of phenylalanine as a free amino 
acid, and in the presence of serum proteins in cell culture media. 
Having established the mutant strains requirement for small peptides for growth in bacterial or 
cell culture media, we then compared the intracellular growth characteristics of the peptide-
dependent mutant strain with the wild-type strain after infection of host cells. We performed 
invasion (infection) assays in both epithelial and macrophage cell lines and determined the 
intracellular growth over 24 h. As shown in Fig. 9, in contrast to the growth defects seen in 
bacterial or cell culture medium, the peptide-dependent mutant showed intracellular growth 
rates comparable to the wild-type strain at all times post-infection, suggesting that 
oligopeptides are available to Salmonella within the SCV. 
 
Fig. 9. Intracellular growth characteristics of the Salmonella ΔaroP ΔpheP ΔτyrP Δmtr ΔpheA strain in 
epithelial and macrophage cell lines. Shown is the relative intracellular growth over 24 h of the wild-type (left 
two bars) or mutant strain (right two bars) harbouring either a control plasmid (white and dark grey bars, resp.) 
or CDH-expressing plasmid (light grey and black bars, resp.). (A), HEK293T human kidney epithelial cell line; 
(B) LoVo human intestinal epithelial cell line; and (C), THP-1 human macrophage cell line. The data shown are 
the means and standard deviations of three, independent assays. 
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Alternatively, it has been reported that the SCV acidifies within a short time post-infection 
(Rathman et al., 1996; Yu et al., 2010). The intracellular growth of the mutant may therefore 
have been due to the spontaneous conversion of prephenate to phenylpyruvate, a reaction 
occurring under acidic conditions, which circumvents the lack of chorismate mutase activity 
due to loss of pheA (Davis, 1953; Katagiri and Sato, 1953). To eliminate this possibility, the 
strains shown in Figs. 7, 8 and 9 also harbour a plasmid encoding a tetracycline-inducible 
cyclohexadienyl dehydrogenase (CDH) which converts prephenate irreversibly into 4-
hydroxyphenylpyruvate and eliminates residual growth of pheA mutants under acidic 
conditions (Kleeb et al., 2007). While the intracellular growth of the mutant was similar to 
that of the wild-type strain regardless of the presence or absence of the CDH plasmid (see. 
Fig. 9), further studies were performed with strains harbouring the CDH plasmid. 
Intracellular growth of additional mutant strains 
To determine whether the absence of a growth defect of the S. Typhimurium ΔaroP ΔpheP 
ΔtyrP Δmtr ΔpheA mutant strain was a trait of the ΔpheA mutation, we also tested the 
intracellular growth characteristic of strains that harbor deletions in other genes involved in 
either aromatic amino acid biosynthesis or uptake, including tyrA and tyrB, trpBA,  pheA and 
trpBA, tyrA and trpBA, or pheA and livKHMGF. The ΔlivKHMGF mutation was included as it 
has been reported that the branched chain amino acid uptake system in E. coli can transport 
phenylalanine in absence of branch chain amino acids (Koyanagi et al., 2004). As shown in 
Fig. 10, the intracellular growth of mutants harbouring mutations in one or more different 
aromatic amino acids are comparabale to that of the wild type, indicating that the observed 
intracellular growth of the pheA strain is not specific for that particular strain nor is it specific 
for a phenylalanine auxotroph, the observation holds true for strains carrying other mutations 
in the aromatic amino acids. Although the relative growth increases (intracellular CFU at 24 h 
relative to 4 h post-infection) were similar, for reasons which are not yet clear, the other 
mutants also showed differing degrees of effects on host cell invasion, likely due to the poor 
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growth in the bacterial growth media which contains very low levels of tryptophan and 
tyrosine. We therefore chose to use the ΔaroP ΔpheP ΔtyrP Δmtr ΔpheA mutant strain for the 
rest of the study. 
 
Fig. 10. Intracellular growth characteristics of SL1344 ∆aroP ∆pheP ∆tyrP ∆mtr strains harbouring 
additional mutations in aromatic amino acid biosynthetic genes. Shown are the intracellular cfu/ml cell 
lysate at the indicated time points post-infection in the LoVo human intestinal epithelial cell line for the wild-
type (open symbols) and mutant strains (filled symbols) indicated in the panels. The results shown are 
representative of at least three, independent experiments performed in duplicates. 
 
Intracellular growth in presence of inhibitors against various host cellular mechanism 
The observation from the above results that the peptide dependent mutant shows no 
intracellular growth defect to the wild-type strain, suggests that the growth of mutant is 
dependent upon an alternative source of phenylalanine other than free amino acids, 
presumably short oligopeptides. Furthermore, due to the uptake limits of the peptide 
transporters in Salmonella, these peptides should be accessed in partially degraded form 
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constituting short peptides of about 5 to 6 amino acids to support the growth of the mutant.  
Also, even if Salmonella gets access to host cells oligopeptides, it cannot use them as a source 
of nutrition as Salmonella lacks any extracellular proteases, which further restricts the 
pathogen to be dependent upon short peptides. We thus considered possible sources of 
peptides which might be available to intracellular Salmonella to contribute to its growth 
within the SCV. 
Every cell (host cell) maintains its cellular homeostasis by targeting proteins, enzymes and 
other metabolites which are no longer required or whose functions are completed for 
degradation to lysosomes. As a result, lysosomes generates a rich pool of amino acids and 
other basic biomolecules which are re-utilized by the host cells for numerous processes. As 
explained previously, cell could target cargo proteins for degradation to lysosomes via three 
different forms of autophagy notably, macroautophagy, microautophagy and chaperone 
mediated autophagy (CMA).  
 Fusion of the SCV with lysosomal compartment is one such possibility which could 
provide access to short peptides to the Salmonella to support its growth. However, numerous 
studies over the years have excluded the possibility of a fusion event between lysosomes and 
the SCV (Garcia-del Portillo and Finlay, 1995; Brumell et al., 2001; Harrison et al., 2004; 
Brumell and Grinstein, 2004), even though the SCV shares certain host makers common to 
lysosomes. We thus decided to examine the intracellular growth of the mutant by using 
inhibitors which block the three forms of autophagy. As depicted in Fig. 11, there is no 
significant difference in the intracellular growth of the mutant to the wild-type strain upon 
inhibiting either macroautophagy with 3-methyl adenine or by preventing acidification of 
lysosomes thus making them functionally inactive using ammonium chloride. Contrastingly, 
on treating host cells with either cyclohexamide at concentrations inhibiting CMA (Finn et al., 
2005) or loading cells with antibodies against Hsc73, which block the activity of lysosomal 
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form of Hsc73 thus completely blocking CMA without effecting the other forms of autophagy 
(Agarraberes et al., 1997) resulted in significant growth inhibition of the mutant when 
compared to the wild-type strain.  
 
Fig. 11. Blocking chaperone-mediated autophagy inhibits the growth of the peptide-dependent mutant, 
but not the wild-type strain. LoVo cells were pre-incubated for 4 h with either 200 µg ml-1cyclohexamide 
(CHX), anti-Hsc73 antibodies, 10 mM 3-methyladenine (3-MA) or 30mM NH4Cl prior to infection with either 
wild-type (grey bars) or mutant strains (white bars). The mutant shows reduced growth when CMA is blocked 
with either CHX or anti-Hsc73 antibodies. Blocking macroautophagy with 3-MA or reducing lysosomal activity 
by preventing acidification of lysosomes through NH4Cl, has no effect on the intracellular growth of the mutant 
strain. . The data shown are the means and standard deviations of three, independent assays where , where p > 
0.05 is considered non-significant (n.s.), **, p < 0.01; as determined with Mann-Whitney U-test. 
 
These results suggest that CMA possibly contributes in the intracellular growth of the mutant 
as similar results were observed in both intestinal epithelial cells and human macrophages. 
However, at this point in time it still remains unclear on how a pathogen residing inside a 
vacuole has access to peptides or nutrients destined for CMA. We therefore, decided to 
examine on the host makers that are present on the SCV membrane. 
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Co-localization of the Salmonella containing-vacuole with components of CMA 
Lysosome associated membrane-1 (LAMP-1) and LAMP-2 are well characterized standard 
markers for the Salmonella-containing vacuole (SCV) or phagosome, which are acquired by 
Salmonella on its SCV very early during the invasion process (Steele-Mortimer et al., 1999). 
Interestingly, there exists three isoforms of LAMP-2, which arises as a result of alternative 
splicing of the lamp2 gene and these differ only at the C-terminus region. As described 
previously only the isoform LAMP-2A is involved in CMA (Cuervo and Dice, 1999), 
nonetheless, both LAMP-2A and LAMP-2B are found to localize in different membrane 
micro-domains in the lysosomes (Kaushik et al., 2006). 
We were therefore interested to know which isoform(s) of LAMP-2 is associated with the 
SCV membrane. HEK293T cells were infected with wild-type Salmonella expressing GFP at 
a MOI of 1:5 (cell: bacteria), and 24 h post infection, cells were fixed, permeabilized and 
incubated with antibodies directed against LAMP-1, LAMP-2A or LAMP-2B. As shown in 
Fig. 12 (a). As expected, LAMP-1 was found to be associated with the SCV membrane; 
however, only the isoform LAMP-2A was found to co-localize (yellow appearance around the 
bacteria) with the SCV membrane, similar to that as observed for LAMP-1. LAMP-2B did not 
show significant association (co-localization) with the SCV membrane, suggesting that the 
presence of LAMP-2A on the SCV membrane was not as a result of lysosomal fusion. To 
further confirm this observation we performed additional co-localization experiments using 
antibodies against lysosomal integral membrane protein 2 (LIMP-2), the lysosomal receptor 
for the mannose-6-phosphate-independent transport of β-glucocerebrosidase and other 
lysosomal hydrolases (Saftig and Klumprman, 2009). As shown in Fig. 12 (a), no significant 
co-localization with the SCV was observed for LIMP-2. These results further supported the 
suggestion that fusion with lysosomal compartments was unlikely to serve as a source of 
peptides for the mutant.  
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a) 
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b)
 
Fig. 12. Co-localization of key components of host chaperone mediated autophagy with the Salmonella-
containing vacuole. Wild-type Salmonella expressing GFP (green) were used to infect HEK293T cells grown 
on coverslips at a multiplicity of infection (MOI) of 5. 24 h post-infection, cells were washed with PBS, fixed, 
and permeabilised with 0.1% Triton X-100. After blocking, the infected cells were incubated overnight at 4°C 
with the indicated primary antibodies. The following day, the coverslips were washed, and incubated with the 
appropriate secondary antibodies conjugated to Alexa-Fluor 546 (red) and examined by laser scanning confocal 
microscopy.(b) Co-localization of Salmonella with Hsc73, co-localization (yellow) was confirmed with heat 
intensity plots . The images shown are representative of at least 25 individual cells per condition performed in 
duplicate on at least three, independent occasions. 
 
 As LAMP-2A was found to co-localize with the SCV, we next determined whether the 
other major component of the CMA complex, Hsc73, was also associated with the SCV 
membrane. As shown in Fig. 12 (b), antibodies specific for Hsc73 were also found to co-
localize with the SCV of intracellular Salmonella.  Similar results were obtained in intestinal 
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epithelial cells and human macrophages, suggesting that the association with CMA 
components is not a cell type effect. 
In addition we also, quantified the percentage of intracellular bacteria which were associated 
with these host cell components. As can be seen in Fig. 13, nearly, 80- 85% of total 
intracellular bacteria harbors LAMP-1, LAMP-2A and Hsc73 on the SCV membrane, 
whereas the other lysosomal markers such as LAMP-2B, LIMP-2 and M6PO4 (Mannose 6 
Phosphate) receptor were absent from the SCV membrane. 
 
 
Fig. 13. Quantification of percentage of intracellular bacteria localized with various markers in the host. 
Of the total intracellular bacteria about 80-85% were found to be associated with LAMP-1, LAMP-2A and 
Hsc73, whereas there was no significant association with other lysosomal markers namely, LAMP-2B, LIMP-2 
and M6PR receptor. 
 
Furthermore, we also performed kinetic studies in order to determine, whether LAMP-2A is 
associated during the early phase of infection around the SCV membrane. As shown in Fig. 
14, the presence of LAMP-2A can be seen as early as 1 h post infection and its localization 
around the bacteria increases with time. Although the presence of LAMP-2A at an early time 
point does not necessarily imply that the CMA apparatus is functionally active and is being 
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utilized by Salmonella as a source for nutrition. But at later time points at about 20-24 h post 
infection, the acquisition of chaperone Hsc73 and Lamp-2A confirms functional activity of 
CMA to support bacterial growth. 
a)         b) 
 
 
Fig. 14. Kinetics of LAMP-2A co-localization. (a) HEK293T cells were infected with wild type GFP 
expressing Salmonella (green). At the indicated time points p.i the monolayer's were fixed and immuno-stained 
with anti-LAMP-2A (red). Localization of LAMP-2A around the bacteria is indicated with arrow heads (white) 
and percent co-localization was quantified at different time point’s p.i. (***= p value < 0.01, *=p<0.5 indicates 
the significance as obtained using Mann Whitney student t test, scale bar= 8µm) 
 
Effect of LAMP-2A and LAMP-1 knock down on intracellular growth. 
As shown above that both LAMP-1 and LAMP-2A localizes with Salmonella-containing 
vacuole, and only LAMP-2A have been reported to have a function in CMA, we therefore 
examined the intracellular growth of the mutant and the wild type strain in LAMP-1 and 
LAMP-2A knockdown cells. We performed shRNA mediated stable knock-down of LAMP-
2A and LAMP-1 in HEK293T cells and compared the intracellular growth of the mutant and 
wild-type strains.  
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a)         b) 
       
Fig. 15. Intracellular growth of mutant is effected by LAMP-2A knockdown. The intracellular growth of 
peptide dependent mutant is significantly reduced in LAMP-2A knockdown cells, however LAMP-1 knockdown 
does not affect the growth of mutant. A) Confirms knockdown of LAMP-1 and LAMP-2A as verified by western 
blots of the whole cell lysates. b) Shows the relative intracellular growth of wild type (clear bar) and peptide 
dependent mutant (black bars) in control, LAMP-1 and LAMP-2A knockdown HEK293T cells. The data shown 
are the means and standard deviations of three, independent assays where , where p > 0.05 is considered non-
significant (n.s.), **, p < 0.01; as determined with Mann-Whitney U-test. 
 
As shown in Fig. 15, reduced expression of LAMP-2A significantly inhibited the growth of 
the peptide-dependent mutant strain compared to the wild-type, further supporting an 
involvement of CMA in intracellular growth of the mutant. However, LAMP-1 knockdown 
did not have any effect on the intracellular growth of both wild-type and mutant strain. 
Significant reductions in the levels of LAMP-2A and LAMP-1 were verified in Western blots 
of whole cell lysates of transfected cells. These results indicated that not only were key 
components of the CMA complex present at the SCV membrane, but functionally active 
CMA was also required to support intracellular growth of the peptide-dependent strain. 
Co-localization of the CMA substrate (GAPDH) with the Salmonella-containing vacuole 
Both the co-localization and inhibitor studies strongly suggested that the host CMA 
components are associated with the SCV and thus CMA could possibly contribute to the 
intracellular growth of Salmonella within the SCV, however it is still not clear, whether the 
CMA apparatus is functionally active at the SCV membrane. We were thus interested in 
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verifying whether a cytosolic CMA substrate translocates to the SCV. For this purpose we 
used one of the best characterized CMA substrate GAPDH (Aniento et al., 1993; Cuervo et 
al., 1994).  We therefore transfected HEK293T epithelial cells with the vector pCMV-
GAPDH-HT expressing a HaloTag fusion with GAPDH which binds fluorescent ligands 
under neutral (cytosolic), but not acidic (lysosomal) conditions.  
 
 
Fig. 16. Co-localisation of the CMA substrate GAPDH with the Salmonella-containing vacuole. HEK293T 
cells stably transfected with the pCMV-GAPDH-HT plasmid, were incubated for 4 h with 500 nM TMR-HT 
ligand prior to infection with S. Typhimurium. 24 h post-infection, cells were fixed and visualized by laser 
confocal scanning microscopy. Shown are the punctate patterns of TMR-HT ligand (A) and co-localisation with 
lysosomal compartments stained with LysoTracker Green (B). (C) Control transfections with pCMV vector 
stained with the TMR-HT ligand. Representative pictures of co-localisation of GFP-expressing Salmonella with 
GAPDH-HT (D, E). The pictures shown are representative of images from two, independent experiments in 
duplicate and at least 25 fields of visualization. 
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On incubating the cells with TMR ligand, it binds with the HaloTag in the cytosol, the 
GAPDH-HT: ligand complex continues to fluoresce and can therefore be used to study 
translocation of CMA substrates such as GAPDH into lysosomes (Seki et al., 2012). The 
transfected cell line was then infected with GFP expressing Salmonella for co-localization 
studies. As shown in Fig. 16, after incubating the transfected cells with the fluorescent ligand 
TMR, co-localization of red fluorescent, punctate complexes were found in close proximity to 
the SCV. These results were therefore suggested that not only the components of CMA are 
associated with the SCV but also CMA is functionally active at the SCV membrane as we 
successfully showed transport of at least one genuine CMA substrate to the SCV.  
Co-localization with plasmid expressing KFERQ-DsRed target motif with SCV 
As 30% of host cytosolic proteins bearing the KFERQ amino acid motif in their protein 
sequence are target to lysosomes by Hsc73 and eventually degraded via CMA, ubiquitously in 
all cell types. In-order to further confirm our previous observation that CMA is functionally 
active at the SCV membrane as GAPDH-HT:ligand complex were present in close proximity 
of SCV we therefore transfected HEK293T cells with a vector containing KFERQ sequence 
fused with DsRed. Similar to other CMA substrates, the KFERQ-DsRed fusion transcript 
should be targeted to lysosomes or vesicles containing CMA components for degradation. The 
transfected cell line was subsequently infected with GFP expressing Salmonella. 20 h post 
infection, the cells were fixed and subsequently imaged. As shown in Fig. 17, the KFERQ-
DsRed transcript product in transfected cells co-localized with GFP-expressing Salmonella.  
The co-localization further confirms our previous results that not only the CMA components, 
LAMP-2A and Hsc73 associated with the SCV, but further that CMA is functionally active at 
the Salmonella-containing vacuolar membrane. Furthermore, in addition to GAPDH, the 
localization with KFERQ-DsRed fusion product indicates, that the substrate proteins 
presumably of CMA are targeted to SCV, which could possibly serve as source of nutrients 
for the bacteria residing within the membrane bound compartment, the SCV. 
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Fig. 17. Co-localisation of the KFERQ-DsRed fusion product with the Salmonella-containing vacuole. 
HEK293T cells were transfected with pCDNA3.1 –KFERQ-DsRed plasmid and selected using neomycin. The 
transfected cells were then infected with GFP expressing Salmonella, after 20hrs p.i the cells were fixed and 
imaged. KFERQ-DsRed construct were found to be co-localized with GFP-Salmonella.  
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Isolation of Salmonella-containing vacuole using magnetic nanoparticles 
A major problem in determination of interacting host proteins and compartments with the 
pathogen containing phagosome has been the isolation of phagosomes free of spurious or 
contaminating proteins and vesicles. Buoyant density gradient centrifugation has generally 
been applied, in which latex beads are pre- or post-loaded with phagosomes containing 
pathogens and purified from fractions taken from the gradients where the latex particles show 
a discrete banding pattern (Desjardins et al., 1994). However, this method is dependent on 
separation from within a gradient of vesicles with similar densities, and cross-contamination 
is unavoidable. Magnetic Cell Separation (MACS) and other column-based methods require 
removal of non-bound material with extensive washing steps, and labile compartments such 
as phagosomes may lose considerable amounts of material and loosely bound proteins. An 
improvement has been the application of Flow-Assisted Cell Sorting (FACS), in which GFP- 
or other fluorescently-labeled bacteria are used to infect cells, and after lysis of the cells, the 
cellular contents are passed through a flow cytometer and fluorescently labelled components 
are diverted from the flow-through for collection. However, the shear forces generated can 
lead to disruption of the phagosomes and the volumes required lead to inefficient 
concentration of the samples. 
We therefore developed a method of SCV isolation which was rapid and required a minimum 
of manipulations in contrast to column- or flow-assisted cell sorting (FACS)-based methods 
where shear forces might lead to disruption of the labile SCV membrane. Furthermore, our 
main objective was to avoid any form of covalent labeling of the bacterial outer membrane to 
ligands with chemical reagents (Lönnbro et al., 2008) which might affect the function of the 
type III secretion apparatus needed for secretion of virulence proteins necessary for 
establishment of the intracellular niche. We therefore labeled Salmonella with carbon-coated, 
paramagnetic cobalt nanoparticles prior to infection in the host cells, followed by recovery of 
the bacteria after lysis of host cells using a magnetic field. 
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Attachment of carboxyl coated magnetic nanoparticles on the bacterial surface 
Bacterial attachment to any surface is related to surface charges both on the bacteria as well as 
on the substratum or target of attachment. Dickson et al., 1989 characterized surface charges 
and their co-relation to bacteria attachment. As per the study, Salmonella typhimurium was 
found to consist of an overall net negative charge with r/e (-) 9.47 to r/e (+) 4.78. We 
therefore, utilized this small, though significant positive charge on to the bacterial surface to 
electrostatically label the bacteria with paramagnetic nanoparticles. For this purpose, we used, 
paramagnetic cobalt nanoparticles of diameter 10 - 50 nm; (Turbo Beads, Zurich) with a 
carboxyl functional group attached to their surface, thus providing the net negative charge for 
attachment via electrostatic interactions on to the positive charge areas (surface) of 
Salmonella. Another, reason for selecting to target the positive charge of Salmonella in 
contrast to the majority negative charge, was, we were not certain about the effect of binding 
of these particles on to the behavior of the bacterium, as otherwise it would have led to more 
particle binding to bacteria and it could have effected, the SPI-I or SPI-II functionality, and 
eventually the isolated SCV, would no longer be a representation of Salmonella’s natural cell 
trafficking within the cell. 
Sonicated, centrifuged nanoparticles were thus incubated with bacterial pellets resuspended in 
1X PBS, at a ratio of 5:1 ratio of nanoparticles: bacteria at 37°C for 20 min. with shaking. The 
bacterial suspension was then filtered through a 0.2 µm filter fitted to a 5 ml syringe. The 
filters were washed twice with two volumes of PBS so as to get rid of any un-bound or free 
floating nanoparticles, the filter was then inverted and the bacteria were recovered in 1 ml of 
PBS collected as a result of backwash into a sterile microfuge tube. These recovered bacteria 
were then further utilized either for infecting THP-1 human macrophages or processed for 
transmission electron microscopy. As shown in Fig. 18 (a) & (b), the bacteria collected after 
the backwash, clearly depicted association with magnetic nanoparticles; furthermore the 
attachment is not uniformly distributed over the entire bacterial surface, but was only 
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concentrated at specific points in aggregation. Additionally, intracellular Salmonella retained 
the electrostatically attached magnetic nanoparticles, within human macrophages as shown in 
Fig. 18 (d), here the nanoparticle tagged bacterium can been seen inside a vacuolar vesicle, 
presumably the SCV or an endosomal compartment.  
 
 
Fig. 18. Attachment of carboxyl coated magnetic nanoparticles on to the bacterial surface. (a) (b) 
represents TEM images of magnetic nanoparticles, attached to bacteria surface marked with arrow heads. (c) & 
(d), represents intracellular Salmonella in THP-1, human macrophage cell line untagged (control) and tagged 
with nanoparticles as marked with arrow heads respectively. Scale bar 1µm. 
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No effect on bacterial viability and invasion rates of nanoparticle-labelled bacteria. 
In order to be certain, that the attachment or interaction of Salmonella, with paramagnetic 
nanoparticles had no significant effect on the viability of the bacteria. We therefore, examined 
the c.f.u of Salmonella before and after incubation with magnetic nanoparticles, under shaking 
conditions at 37°C. Sonicated, nanoparticles were incubated, with bacterial pellets 
resuspended in 1X PBS, at a ratio of 5:1 & 10:1 ratio of nanoparticles: bacteria at 37°C for 20 
min. and 40 min respectively under continuous shaking conditions. The c.f.u was plated 
before and after incubation, in order to determine the effect (if any) of nanoparticle 
attachment on the viability of Salmonella. As shown in figure 19 (b), the total c.f.u before 
incubation and after incubation with magnetic nanoparticles, both at a higher ratio and for 
longer time period of incubation, remains same, suggesting that the nanoparticle did not affect 
the viability of the bacteria.  
Fig. 19. Effect on Invasion rate and viability of bacteria upon attachment with nanoparticles. a) Confluent 
monolayers of THP-1 macrophages were infected with nanoparticle labeled and non-labelled bacteria at an MOI 
of 1:5 (cell: bacteria) to compare the invasion rates after 2 h p.i  b) Bacteria were incubated with nanoparticles 
for 20 min and 40 min, and viability was determined by determining the intracellular the cfu/ml cell lysate. 
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We then further determined, whether the attachment of nanoparticles had any effect on the 
invasion process of Salmonella. For this purpose, we infected pre-seeded THP-1 human 
macrophages, with untagged Salmonella or nanoparticle tagged bacteria at a MOI of 1:5 (cell: 
bacteria). Invasion rates were determined by dividing the intracellular c.f.u at 4 h p.i to that of 
2 h p.i both for control group and the test group. As depicted in Fig. 19 a) the labeling of 
bacteria with paramagnetic nanoparticles had no significant effect on the invasion rates of 
Salmonella as both the bacterial groups were found to be 30% invasive in THP-1 cells. 
SCV purification and analysis 
Salmonella expressing green fluorescent protein (GFP) and bound with carbon-coated, 
paramagnetic cobalt nanoparticles, were used for infecting THP-1 macrophage cells at an 
MOI of 1:10 (cell: bacteria). After 24h post infection, the host cells were lysed and bacteria 
were recovered in the presence of a magnetic field. The recovered cell lysates were then 
placed in a magnetic field (Single Place Magnetic Stand, Ambion, USA) and the supernatant 
was carefully removed and discarded, and replaced by 1 ml of a 1X PBS/2% sucrose solution. 
The recovered bacteria were then further processed for analysis either by microscopy or 
Western blotting, by examining the presence or absence of the SCV markers atthe membrane 
surface. 
a) Microscopic analysis 
Purified SCV’s were incubated in the presence of antibodies against LAMP-1 and examined 
by fluorescence microscopy. As shown in Fig. 15 (upper row), GFP-expressing Salmonella 
showed exterior labeling with LAMP-1, indicating that the SCV membrane in these 
preparations was intact. Also, as shown previously in Fig 12, that intracellular Salmonella 
within the SCV is associated with LAMP-2A, therefore we also incubated the purified SCV’s 
in presence of antibodies against LAMP-2A. Consistent with our previous results, the purified 
SCV also show presence of LAMP-2A as shown in Fig. 20 (bottom row) on its membrane 
surface, similar to that as observed for LAMP-1. 
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Fig. 20. Microscopic analysis of purified SCV. Representative immunofluorescence pictures of purified SCVs 
recovered from THP-1 macrophage infected with paramagnetic nanoparticle labeled, GFP-expressing 
Salmonella and stained for LAMP-1 (upper row). The lower row shows acquisition of LAMP-2A on the intact 
membrane of the SCV. The right panel is a close-up of an individual SCV showing a single bacterium (left), 
LAMP-1 staining (middle) and a merge of the two emission spectra (right). 
 
These results indicated that the isolated SCV’s contained both LAMP-1 as well as LAMP-2A. 
Moreover, the labelling with both LAMP-1 and LAMP-2A at the SCV membrane also 
indicated that the membrane of these isolated SCV’s is intact. Furthermore, these results with 
isolated and purified SCV’s further confirmed our previous observation that the key CMA 
component LAMP-2A is associated with Salmonella-containing vacuole (SCV). 
b) Western blot analysis 
In order to further verify the presence or absence of SCV-associated host proteins on the SCV 
membrane, we performed Western blotting with the purified Salmonella-containing vacuoles. 
 Salmonella expressing green fluorescent protein (GFP) were bound with carbon-coated, 
paramagnetic cobalt nanoparticles prior to infection of macrophage, followed by recovery of 
the bacteria after lysis of host cells using a magnetic field. As a control, nanoparticle-bound 
Salmonella were heat-killed, and incubated with macrophage for uptake by phagocytosis. 
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a)      b) 
Fig 21. Western blot analysis of purified SCV. Purified SCVs recovered from THP-1 macrophage infected 
with either live (SCV) or heat-killed (killed) GFP-expressing Salmonella were subjected to SDS-PAGE and 
Western blotting using antibodies against the indicated host proteins. (b) Quantification of the relative amounts 
of the indicated host proteins present in SCVs purified from macrophage infected with either live (open bars) or 
heat-killed Salmonella. Signal intensities were determined relative to a constant amount of non-infected cell 
lysates. The data shown are the means and standard error of at least two, independent experiments. Statistical 
significance was determined by a two-way Annova, where p > 0.5 is considered non-significant (n.s.); **, p < 
0.01; ***, p < 0.001. 
 
The purified SCV preparations were then subjected to SDS-PAGE followed by Western 
blotting using specific antibodies against various lysosomal markers. As expected, LAMP-1, 
LAMP-2A and Hsc73 were present in purified SCV preparations, whereas LAMP-2B and 
LIMP-2 were significantly reduced or absent compared to control phagosomes containing 
heat-killed Salmonella, which showed the prominent presence of lysosomal markers, as 
expected for mature lysosomes (Fig. 20a). Interestingly, we observed significantly higher 
amounts of both LAMP-2A and Hsc73 in SCV preparations with live Salmonella compared to 
phagocytosed dead Salmonella, suggesting an enrichment of these proteins at the SCV 
membrane as demonstrated in the quantification plot shown in Fig. 20 (b). 
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Furthermore, the CMA substrate, GAPDH was also present in low, but appreciable levels in 
the SCV preparations. These results further confirmed our previous observation as shown in 
Fig. 16 with co-localization studies using a pCMV-GAPDH-HT construct where SCV co-
localized with GAPDH (CMA substrate), indicating functional nature of CMA on SCV 
membrane. 
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Discussion 
Autophagy: a friend or foe for Salmonella? 
Autophagy is a fundamental catabolic process of eukaryotic cells which is required for the 
elimination of cytosolic protein aggregates, denatured or damaged proteins, enzymes which 
are no longer required, and damaged cytosolic organelles by delivering them to lysosomes for 
degradation. In this manner, autophagy plays an essential role in maintaining cellular 
homeostasis in response to numerous cellular and environmental stresses. Autophagy 
pathways also play an important role in multiple aspects of innate and adaptive immunity 
(reviewed by Virgin and Levine, 2009; Levine et al., 2011).  
 Autophagy also plays a crucial role in generating innate immune responses against 
microbial infections. During infections, autophagy is responsible for the recognition, capture, 
selective targeting and degradation of intracellular bacteria and viruses (Levine, 2005; 
Deretic, 2011). Antibacterial autophagy also plays a role in controlling intracellular bacterial 
replication and generating host innate immune responses in host cells. Evidence from recent 
studies has suggested that intracellular bacteria residing within vacuoles can be targeted to 
lysosomes for degradation by activation of autophagy (Levine, 2005; Deretic, 2011). 
Furthermore, access to the cytosol for intracellular bacteria, caused by damaged vacuoles, 
allows autophagic targeting of bacteria by delivering them to lysosomes (Ogawa et al., 2009; 
Collins and Brown, 2010; Fujita and Yoshimori, 2011).  
 Autophagosomes, in addition to sequestering cytosolic material for degradations also 
play a critical role in selectively targeting material derived from intracellular pathogens for 
degradation by means of receptor-ligand interactions. Intracellular bacteria can induce the 
formation of ubiquitinated protein aggregates which are recognized by cargo adaptors or 
receptors meant to target these for degradation (Collins and Brown, 2010; Fujita and 
Yoshimore, 2011). Well-characterized autophagy receptors such as p62 (sequestosome 1 or 
SQSTM1) (Pankiv, et al., 2007), NBR1 (neighbour of BRCA1 gene 1 ) (Kirkin et al., 2009), 
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NDP52 (nuclear dot protein, 52 kDa) ( Thurston et al., 2009) and OPTN (optineurin) (Wild et 
al, 2011) together represent a category of pattern recognition receptors, known as 
sequestosome 1/p62-like receptors (SLRs) and these link autophagy to innate immunity 
(Deretic et al., 2011 and Ogawa et al., 2011). These receptors bind to both ubiquitin and 
ATG8 family of proteins such as LC3s and GABARAPs and eventually mediate targeting of 
ubiquitinated cargo to autophagy (Johansen and Lamark, 2011). 
 Salmonella serovar typhimurium is a facultative intracellular pathogen which infects a 
wide variety of hosts. Salmonella follows a bimodal life style within its host cells. The 
pathogen usually resides in a vacuolar compartment known as the Salmonella-containing 
vacuole (SCV), within which the pathogen replicates and secretes a number of effector 
proteins through type III secretion systems into the host cell cytosol. Studies have found that 
the bacterial type III secretion system, which spans both the bacterial and SCV membranes, 
can lead to damage of the SCV membrane leading to bacterial escape into the host cell cytosol 
where they can be detected by the autophagy process (Birmingham et al., 2006). In the HeLa 
cell line, approximately, 25% of Salmonella Typhimurium become cytosolic, where the 
bacteria become decorated with polyubiquitinated proteins, and the ubiquitinated bacteria are 
then detected by cargo adaptor, NDP52 (Thurston et al., 2009). Salmonella Typhimurium 
invasion of host cells also leads to activation of the TLR4 signalling pathway, which leads to 
phosphorylation of TBK-1 (Yuk and Jo, 2011). Through a cascade of signalling events, this in 
turn leads to recruitment of NDP52, which then results into phosphorylation of OPTN, 
another autophagy receptor (Thurston et al., 2009; Wild et al., 2011). Phosphorylation of 
OPTN further enhances its ability to interact with autophagic proteins LC3, enabling the 
elimination of the pathogen by activation of a form of autophagy known as xenophagy (Wild 
et al., 2011). Furthermore, recent studies have revealed that NDP52 preferentially interacts 
with the LC3 isoform C (LC3C) and this selective interaction is involved in recruitment of 
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ATG8 protein family proteins to cytosolic bacteria which can result in elimination of 
Salmonella Typhimurium (von Muhlinen et al., 2012).  
 Diacylglycerol (DAG), a lipid second messenger generated by phospholipase D, has 
also been reported to be associated with autophagy-targeted Salmonella, and is essential for 
antibacterial autophagy through protein kinase Cδ signalling (Shahnazari et al., 2010). 
Additionally, a recent study has revealed that the cytosolic lectin Galectin 8 (LGALS8) plays 
a novel role in detecting bacterial invasion by binding to host glycans during invasion by 
Salmonella. This binding of Galectin 8 leads to NDP52 recruitment eventually resulting in 
antibacterial autophagy (Thurston et al., 2012). A similar function for LGALS8 has been 
reported in case of Shigella invasion. 
 Another cargo adaptor, p62/SQSTM1, is recruited by polyubiquitin-coated Salmonella 
for degradation of the pathogen by xenophagy (Zheng et al., 2009). NBR1 is another cargo 
adaptor which possesses a similar domain structure required for interaction with LC3 proteins 
and ubiquitin. The N-terminal region of NBR1 contains a PBI domain which is required for 
interacting with LC3 proteins, and its C-terminal regions possess a UBA domain which 
interacts with ubiquitin (Kirkin et al., 2009; Lamark et al., 2009). NBR1 interacts with p62 to 
form oligomers which are recruited to polyubiquitinated Salmonella which can then be 
degraded by autophagy processes (Kirkin et al., 2009; Lamark et al., 2009).  
 Salmonella targeted by autophagy are either labelled with ubiquitin or DAG, 
suggesting that at least two independent pathways promote bacterial degradation. 
Furthermore, recruitment of NDP52 by Galectin 8 to damaged vacuoles suggests involvement 
of non-ubiquitin pathways also involved in targeting bacteria for clearance through 
autophagy. In fact, Galectin 8-mediated recruitment of NDP52 shows a temporal pattern of 
autophagy induction, i.e. Galectin 8-mediated recruitment of NDP52 occurs first, followed by 
ubiquitin-dependent NDP52 recruitment. These observations highlight that different pathways 
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can act at distinct steps during bacterial infection and results in targeting and clearance of the 
pathogen by autophagy.  
 In contrast, a recent study examined the fate of cytosolic Salmonella in HeLa epithelial 
cells through live cell imaging. It was observed that a population of cytosolic Salmonella was 
associated with p62 or LC3 and these bacteria replicated at a much faster rate compared to 
bacteria residing within the SCV, which showed little or no association with p62 or LC3 (Yu 
et al., 2014). Furthermore, depletion of these autophagy components (p62 and LC3) 
significantly reduced replication of cytosolic Salmonella in HeLa cells (Yu et al., 2014). In 
addition, a similar observation was reported in another study where a knockdown of Rab1, a 
GTPase required for autophagy of Salmonella, resulted in decreased Salmonella replication in 
HeLa epithelial cells (Huang et al., 2011). These results have been suggested to indicate that 
autophagy facilitates Salmonella replication in epithelial cells.    
 According to a model proposed for p62-dependent autophagy favouring Salmonella 
replication in host cytosol, it is speculated that cytosolic Salmonella acquire nutrients which 
are supplied by autophagy for its replication (Yu et al., 2014). This model further proposes 
that at least three populations of Salmonella exist within infected host cells. The first 
population is represented by bacteria which reside within the Salmonella-containing vacuole 
(SCV), where the bacteria appear to replicate slowly, as they do not associate with 
autophagosomes and have difficulty in acquiring nutrients from the cytosol. The second group 
represents those bacteria with damaged SCV membranes, and which are partially exposed to 
the host cell cytosol where they are inefficiently marked with ubiquitin and only partially 
associated with autophagosomes (Birmingham et al., 2006). However, this population is able 
to acquire limited amount of nutrients and replicate faster. The third population of bacteria is 
completely exposed to cytosol and are efficiently marked with ubiquitin and show higher 
levels of association with autophagosomes. This third population acquires sufficient levels of 
nutrients and show the most rapid intracellular replication (Yu et al., 2014). These hyper-
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replicating bacteria lead to host cell death as a result of apoptosis at later time point’s post-
infection and are capable of initiating secondary infections.  
 The SCV is often regarded as a nutritionally-deprived compartment for the Salmonella 
as the pathogen has no or limited access to host cytosol (Dandekar et al., 2012). Auxotrophic 
mutants of Salmonella have been reported to show defective intracellular replication and are 
also less virulent in a murine model of Typhoid (Fields et al., 1986). Virulent Salmonella 
have been reported to modify the SCV in order to escape lysosomal killing and hence 
proliferate in host cells (Haraga et al., 2008). The lysosomal killing of Salmonella within the 
SCV is by-passed as the SCV shows no or only very limited association with mannose-6-
phosphate receptor (M6PO4), an essential marker necessary for lysosomal-mediated delivery 
of hydrolytic enzymes (Kornfeld and Mellman, 1989; Saftig and Klumperman, 2009). 
However, despite the nutrient limitation within the SCV, Salmonella is still able to replicate. 
This is indicative of a successful adaptation of Salmonella to this nutrient limited intracellular 
niche/environment. Our results provide the first evidence for a unique mechanism whereby 
intracellular Salmonella gain access to host cell cytosol from within its membrane-bound 
compartment to acquire nutrients. 
 The results of this study indicate that Salmonella Typhimurium acquires small 
peptides by co-opting the host cell chaperone-mediating autophagy (CMA) pathway of 
cytosolic protein turnover. CMA is a selective host cell protein turnover pathway involved in 
the transport of cytosolic proteins into lysosomes for degradation (Dice et al., 2007; Orenstein 
and Cuervo, 2010). An estimated 30% of all cytosolic proteins are turned over through this 
mechanism (Wing et al., 1991) and which is always active at basal levels in nearly all cell 
types (Kaushik and Cuervo, 2009). We have shown both in isolated intact SCV’s and within 
host cells that the SCV is associated with the key components of CMA, LAMP-2A and 
Hsc73. Moreover, due to the ubiquitous nature of CMA in nearly all cell types, intracellular 
Salmonella would therefore have access to pre-formed amino acids even in non-absorptive 
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cell types such as macrophages. This would explain why Salmonella present within SCV 
successfully survives and replicates in infected macrophages whereas Salmonella present in 
the cytosol are killed in macrophages (Beuzón et al., 2002). 
 Invasion assays using host cells deficient in LAMP-2A or inhibitors of CMA 
significantly affect the intracellular growth of the peptide-dependent mutant strain (KT7650) 
which can neither take up free, aromatic amino acids nor synthesize the aromatic amino acid 
phenylalanine. The results suggest that CMA as a source of amino acids contributes an 
estimated 20-30% to the intracellular growth of Salmonella, indicating that a significant 
fraction of the intracellular growth of Salmonella is independent of both de novo amino acids 
biosynthesis and free amino acids. However, fusion with lysosomes could serve as a source of 
peptides and amino acids, our results are consistent with a more restrictive interaction with 
lysosomal compartments, as indicated by the presence of both LAMP-1 and LAMP-2A on 
SCV’s but exclusion of LAMP-2B, the mannose-6-phosphate receptor M6PO4, and LIMP-2, 
all markers which are present on mature lysosomal membranes but within particular micro-
domains (Kaushik et al., 2006). 
 As previously reported for cytosolic Salmonella using autophagy to acquire nutrients 
for replication in the cytoplasm, or results also suggest that Salmonella within the SCV can 
also acquire nutrients via a more specific form of autophagy, i.e. CMA, in order to support its 
intracellular growth within the SCV. By co-opting CMA, Salmonella has an additional 
advantage over cytosolic Salmonella in specialized cells such as macrophages. Both these 
observations imply a unique shift in the paradigm where host cellular pathways meant for 
elimination of intracellular pathogens are hijacked/utilized by Salmonella for its own benefit. 
This utilization of autophagy, either specific or general, by intracellular Salmonella also 
marks a unique adaptation towards host-pathogen interactions where a pathogen depending 
upon its intracellular state (either in cytosol or within SCV) adopts to that form of autophagy 
for its own survival. 
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 Autophagy has recently been considered as an important defence mechanism by the 
host cells to clear intracellular microbes. However, it now appears that bacterial pathogens 
such as Legionella, Coxiella, Yersinia, Brucella etc. have evolved mechanisms to evade 
autophagic recognition or even co-opt the autophagy machinery for their own benefit as a 
replicative niche. Pathogens such as Listeria or Shigella, have evolved mechanisms to escape 
from their internalization vacuole into cytosol, and thus avoid phygolysosomal degradation 
(Ogawa et al., 2005; Pay et al., 2007). Some pathogens such as Mycobacterium (Stamm et al., 
2004) and  Legionella (Joshi and Swanson, 2011) interfere with the conversion of this vacuole 
into a phagolysosmes. Other pathogens such as Coxiella burnetii and Yersinia 
pseudotuberculosis accumulate autophagy markers on the membrane of their vacuole and thus 
promote their own replication by autophagy (Romano et al., 2010; Morea et al., 2010).
 Brucella abortus subverts the autophagy machinery to promote the infection process 
within host cells. Shortly after invasion of host cells, Brucella resides within the Brucella 
containing vacuoles (BCV). These vacuoles interact with endosomes and acquire endosomal 
markers and eventually fuse with ER-derived membranes and develop a replicative 
compartment (Celli et al., 2004). These ER-derived BCV develop into autophagosome-like 
BCV (aBCV), a process similar to the formation of autophagosomes (Starr et al., 2012). 
These observations from different intracellular pathogens strongly suggest that autophagy 
should not be strictly considered as an antibacterial host response to eliminate pathogens. 
Furthermore, these different means of avoiding or subverting autophagy highlight the degree 
of molecular complexity that underlies bacterial pathogen: host interactions, and point out 
difficulties in proposed therapeutic modulation of autophagy against bacterial infections. 
Acquisition of CMA components 
Infection of epithelial cells with intracellular pathogens such as Shigella and Salmonella, 
results in initiation of intracellular amino acid starvation conditions. This amino acid 
deprivation is induced due to damage in host cell membrane during the invasion process 
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(Tattoli et al., 2012). However, in the case of Salmonella infections, this amino acid starvation 
stress condition within the host cell lasts only for a short period of time as the host cell 
membrane integrity is rapidly normalized. We suggest that it is this short-lived intracellular 
amino acid stress period induced during Salmonella infections results in the activation of 
various autophagy pathways, including CMA, and as a result during the course of SCV 
maturation, Salmonella acquires LAMP-2A. As the maturing SCV resembles an early 
endosome bearing markers such as EEA-1, vacuolar ATPases and other Rab proteins, the host 
cell may not distinguish between a maturing SCV and an early endosome, and therfore target 
LAMP-2A destined for endosomes to the SCV. As shown in figure xx , that SCV is 
associated with LAMP-2A as early as 1hr post-infection. Although LAMP-2A is acquired 
early during the infection process, it does not confirm that CMA is functionally active at this 
stage of infection. 
 The role of lipids and other host proteins have been extensively studied with regard to 
the membrane dynamics and integrity of the SCV. High levels of cholesterol are detected at 
the SCV membrane. Studies examining the importance of cholesterol during infections have 
reported that nearly 30-40% of total cellular cholesterol is recruited to the SCV (Catron et al., 
2002), where it plays an important role in T3SS translocon function (Hayward et al., 2005). 
The Salmonella SPI-2 effector protein SseJ plays a role in esterification of cholesterol from 
the SCV membrane in infected cells. Furthermore, this esterification of cholesterol as lipid 
droplets by SseJ is critically important for bacterial intracellular replication (Nawabi et al., 
2008). Interestingly, CMA is activated upon removal of cholesterol from the lysosomal 
membrane either by chemical treatments, or under conditions of stress such as free radicals 
(Kaushik et al., 2006). The reduction of cholesterol from lysosomal membrane allows LAMP-
2A to multimerize, whereas it is normally present as a single molecule integrated in the 
membrane (Kaushik et al., 2006). The rate limiting step in the CMA process is the 
multimerization step, which results in formation of the LAMP-2A translocon through which 
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target proteins are transported into the lysosomal lumen for degradation. Thus, we speculate 
that the esterification activity of SseJ on SCV membrane may result in reduction of the 
cholesterol levels in the SCV membrane and thereby allow previously acquired LAMP-2A to 
function, explaining why cholesterol esterification by SseJ is involved in promoting bacterial 
replication. 
Implications of this study 
Faecal shedding of Salmonella by asymptomatic carriers of Salmonella is often observed in 
humans and animals under stress conditions. One such example is increased faecal shedding 
of Salmonella Typhimurium in pigs and cattle upon transport (Isaacson et al., 1999; Callway 
et al., 2006). Reactivation of asymptomatic infections is therefore of high zoonotic 
importance, in particular for domestic animals in food production such as cattle and swine. 
Interestingly, CMA is activated under stress conditions (Orenstein and Cuervo, 2010), and the 
higher faecal loads may reflect a response of intracellular Salmonella to increased levels of 
nutrients due to the increased activity of CMA. In this manner, the intracellular growth of the 
pathogen is coupled to the fitness status of its host. Stress conditions experienced by the host 
would provide a nutritional shift within the SCV, resulting in increased proliferation of 
otherwise dormant Salmonella. 
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Outlook 
During the course of this study we developed a novel method to successfully isolate intact 
Salmonella-containing vacuoles in macrophages using paramagnetic nanoparticles. The 
method described for isolation of SCV is rapid, gentle and could be utilised for analysing host 
proteins that interact with pathogen residing in a vacuole. These highly purified SCVs can be 
used for in-depth proteomic analysis of host proteins associated with the SCV in an effort to 
determine other possible pathogen: host interactions involved in intracellular survival and 
replication. 
 The identification of the chaperone-mediated autophagy pathway as not only 
interacting with the SCV, but also capable of delivering carbon-units and sources of amino 
acids, may also reveal a novel means of combatting intracellular pathogens. Host cell 
cytosolic proteins which are delivered to the lysosome for degradation through the CMA 
pathway require a KFERQ-targeting motif for recognition as a CMA substrate. This 
observation suggests new possibilities for the targeting of antibacterial peptides to this 
otherwise protected niche within host cells. Furthermore, it would be interesting to determine 
whether the other serovars of Salmonella and other intracellular pathogens residing in a 
vacuolar niche within the host cells can also access cytosolic peptides via the CMA pathway. 
The novel intracellular compartment markers and isolation methods and approaches resulting 
from this study may find far wider application in future studies in host: pathogen interactions. 
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SUPPLEMENTS 
Table 6. List of Cell Lines used in the study. 
Cell Line Description Source or reference* 
LoVo Human colon intestinal epithelial cells ATCC Cat. Nr. CCL-229 (Drewinko et al., 1976) 
THP-1 Human acute monocytic leukemia cells DSMZ Cat. Nr. ACC-16 (Tsuchiya et al., 1982) 
HEK293T 
Human kidney epithelial cells 
constitutively expressing the simian virus 
40 (SV40) large T antigen 
ATCC® CRL-11268 
HEK293T/GAPDH-
HT 
 
HEK293T cells stably transfected with 
pCMV-GAPDH-HT plasmid under 
neomycin selection. 
This study 
HEK293T/KFERQ-
DsRed 
 
HEK293T cells stably transfected with 
pCDNA3.1-KFERQ-DsRed2 plasmid 
under neomycin selection. 
This study 
HEK293T/ LAMP-
1 knockdown 
HEK293T cells stably transfected with 
anti-LAMP-1 ShRNA plasmid to 
knockdown LAM P-1 under puromycin 
selection. 
This study 
HEK293T/ LAMP-
2A knockdown 
HEK293T cells stably transfected with 
anti-LAMP-1 shRNA plasmid to 
knockdown LAMP-2A under puromycin 
selection. 
This study 
Abbreviations: ATCC, American Type Culture Collection; DSMZ, Deutsche Sammlung von 
Mikroorganismen und Zellkulturen 
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Table 7. List of Bacterial strains  
Strain Genotype/Relevant features Source or reference 
2994  SL1344 S. Typhimurium hisG46 rpsL Hoiseth and Stocker, 
1981 
6220 ΔaroP ΔpheP ΔtyrP Δmtr ΔpheA This study 
6292 ΔaroP ΔpheP ΔtyrP Δmtr ΔpheA ΔtrpBA This study 
7586 ΔaroP ΔpheP ΔtyrP Δmtr ΔtrpBA This study 
7598 ΔaroP ΔpheP ΔtyrP Δmtr ΔtyrA ΔtyrB This study 
7740 ΔaroP ΔpheP ΔtyrP Δmtr ΔtyrA ΔtrpBA This study 
7650 ΔaroP ΔpheP ΔtyrP Δmtr ΔpheA+GFP This study 
7750 ΔaroP ΔpheP ΔtyrP Δmtr ΔpheA(pACYC184) This study 
7752 ΔaroP ΔpheP ΔtyrP Δmtr ΔpheA (pMHEtetCDH) This study 
7762 SL1344 (pACYC184) This study 
7764 SL1344(pMHEtetCDH) This study 
8010 ΔaroP ΔpheP ΔtyrP Δmtr ΔlivKHMGF This study 
8016 ΔaroP ΔpheP ΔtyrP Δmtr ΔpheA ΔlivKHMGF This study 
 
Table 8. List of Plasmids 
Plasmid Relevant features Reference/ source 
 
pACYC184 
cat tet p15a origin This study 
 
pMHEtetCDH 
cat tetOP-cdh+ p15a origin Kleeb et al., 2007 
 
pcDNA3.1(+) 
bla neo PCMV SV40ori Invitrogen 
 
pCMV-GAPDH-HT 
bla neo PCMV SV40ori Seki et al., 2012 
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Table 9. List of primers 
Name Sequence (5’-3’) Gene Reference 
AROAH1P1 
 
TCGGCGCGCCAGCCCGTCGACTGGCGCAACAG 
AAGACTTAGGCCATATGAATATCCTCCTTAG 
 
aroA 
 
This study 
AROAH2P2 
 
CTGTGGGGTTTTTATTTCTGTTTTTTGAGAGTT
GAGTTTCATGTGTAGGCTGGAGCTGCTTCGA 
 
aroA 
 
This study 
AROAF 
 
TTTTCATCCCCACGGCCAGT 
 
aroA This study 
AROAR 
 
ATAAAAATAGTGCGAATACG 
 
aroA This study 
AROPHF 
 
CATGTTTCAAAGCTTTAACTGTGCACAAATGT 
 
aroP 
 
This study 
AROPBR 
 
CCGCTGATATGGATCCAATGGTTATACGTGGG 
 
aroP 
 
This study 
PHEAH1P1 
 
GGAGGCCTTTTTTATTGATAACAAAAAAGGCA 
ACACTATGGTGTAGGCTGGAGCTGCTTCGA 
 
pheA 
 
This study 
PHEAH2P2 
 
GTCGCAGGGATGAAGAAAAGCCGTTTTATTG 
AACGTCAGGCCATATGAATATCCTCCTTAG 
 
pheA 
 
This study 
PHEAF 
 
GAACAAGAAGGCCTCCCCCA 
 
pheA This study 
PHEAR 
 
CGCCATCTTCACCCTGCAGG 
 
pheA This study 
MTRH1P1 
 
AGATAGTCACACTATAAATGACTGGAGAGAG
AGCTGAATGTGTAGGCTGGAGCTGCTTCGA 
 
mtr 
 
This study 
MTRH2P2 
 
GATGAAAACAGCTCATCCGGCTCGTTCAATTA
CTGGTACACCATATGAATATCCTCCTTAG 
 
mtr 
 
This study 
MTRF 
 
CTGGTACAGTGCAGCGTATT 
 
mtr 
 
This study 
MTRR 
 
TACCATTTCGCGGACTTGTG 
 
mtr 
 
This study 
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PHEPH1P1 
 
CTCAATAAAAACGATACAGGGGTAGGACGTG
AAAAACGCGGTGTAGGCTGGAGCTGCTTCGA 
 
pheP 
 
This study 
PHEPH2P2 
 
ATCGCATGAACATGGGATCGGGCAAAAAAGT
TAATGAGCCATATGAATATCCTCCTTAG 
 
pheP This study 
PHEPF 
 
CGGCAGCGAGAGCGAAATGT 
 
pheP This study 
PHEPR 
 
AGGGACATTGCGGCATTAAT 
 
pheP This study 
LIVKH1P1 
 
CAAAACATATAACATCACGAATGGGGATACA
GGCACATGGTGTAGGCTGGAGCTGCTTCGA 
 
livK 
 
This study 
LIVKF 
 
GTCTGCTTTTTAACCAGCAA 
 
livK 
 
This study 
LIVKR 
 
TAAGGTAACCTTTTTAAACC 
 
livK 
 
This study 
LIVFH2P2 
 
CACGCGCTTCCCCCCTGGCACAGTCTAACCGC
CCAGATAGCATATGAATATCCTCCTTAG 
 
livF 
 
This study 
LIVFF 
 
CGCCGGAAGAGATCCGCAAC 
 
livF 
 
This study 
LIVFR 
 
GAAAAATTTTACCGCTTGCC 
 
livF 
 
This study 
TRPBAH1P1 
 
CAGTTTTTCAGACACTGCGCGCATATTAAGGA
AAAAACATGGTGTAGGCTGGAGCTGCTTCGA 
 
trpBA 
 
This study 
TRPBAH2P2 
 
CATTAAGCCGCCAGCGTTATGCTGACGGCTTA
ACCCGTTACATATGAATATCCTCCTTAG 
 
trpBA 
 
This study 
TRPBF 
 
CAAAGATGCTCGTCTTCTGGC 
 
trpB 
 
This study 
TRPBR 
 
GGACAAAAGCGCCTTCCCGG 
 
trpB 
 
This study 
TRPAF 
 
CCGCGGAGATAAAGACATCT 
 
trpA 
 
This study 
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TRPAR 
 
ATTCTGGTTCGGCGCCAGCC 
 
trpA 
 
This study 
TYRAH1P1 
 
GAGCGGCCAGCTGGCGGTGCGCGTCGCATAA
GAGGTTGTTATGTGTAGGCTGGAGCTGCTTCG 
 
tyrA 
 
This study 
TYRAH2P2 
 
AGCCAGCAAAGCTGGCTTTTAGTATAGATGTC
ATCATTATGGCATATGAATATCCTCCTTAG 
 
tyrA 
 
This study 
TYRAF 
 
CGTGAAATTCATAAAGATTT 
 
tyrA 
 
This study 
TYRAR 
 
CATAACGGTTCCTTAAACGA 
 
tyrA 
 
This study 
TYRBH1P1 
 
GTTATTTCCTGCCCTCTGTAAACCTGGAGAAC
CATCGCGTGGTGTAGGCTGGAGCTGCTTCGA 
 
tyrB 
 
This study 
TYRBH2P2 
 
GGAGGGCACTGTTATCGCCGTCCGGCCTGAAT
ATTACATGACCATATGAATATCCTCCTTAG 
 
tyrB 
 
This study 
TYRBF 
 
TCTCGTCCTTCCGGTTTATT 
 
tyrB 
 
This study 
TYRBR 
 
GATGATCACAACAGCTATTG 
 
tyrB 
 
This study 
TYRPH1P1 
 
CGGATATCACCGTTCTTTGTTACCGGGGTAGT
AGAAAGCGTGTGTAGGCTGGAGCTGCTTCGA 
 
tyrP 
 
This study 
TYRPH2P2 
 
GTAATCTTTGCCTGGCGTTAACCTGGATCGGG
CAGGAACCCCATATGAATATCCTCCTTAG 
 
tyrP 
 
This study 
TYRPF 
 
GTAATGCCTTACCCTGCGCC 
 
tyrP 
 
This study 
TYRPR 
 
CCATAGCGTGATGATTATCG 
 
tyrP 
 
This study 
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Table 10. Antibiotics used in the asssays. 
 
Antibiotic Final concentration Stock solution 
Chloramphenicol 50µg/ml 10mg/ml 
Gentamycin 50µg/ml & 10µg/ml 10mg/ml 
Kanamycin 50µg/ml 10mg/ml 
Neomycin 5µg/ml 1mg/ml 
Puromycin 5µg/ml 1mg/ml 
Tetracyclin 0.1µg/ml 100µg/ml 
 
Table 11. List of primary Antibodies 
 
Antibodies Clone/Company Type Working conc. 
Hsc 73 13D3 (Abcam) Mouse mAb 
(IgM) 
1/100 IF 
1/5000 WB 
LAMP-2A 
(Abcam) 
Generated against a 
peptide 
corresponding to 
amino acids 350-410 
of human LAMP-2A 
isoform 
Rabbit pAb 
(IgG) 
1/100 IF 
1/5000 WB 
LAMP-2B Abcam Rabbit pAb 
(IgG) 
1/100 IF 
1/5000 WB 
LAMP-1 ID4B (Santacruz 
biotech) 
Rat MAb 
(IgG2a) 
1/100 IF 
1/5000 WB 
LIMP-2 C-18 (Santacruz 
biotech) 
Goat pAb 
(IgG) 
1/100 IF 
1/5000 WB 
M6PO4 Abcam Goat pAb 
(IgG) 
1/100 IF 
GAPDH Abcam Rabbit pAb 
(IgG) 
1/100 IF 
1/5000 WB 
Anti GFP 7G9(Acris) Mouse mAb(IgG1) 1/5000 
Note: - IF: - Immunofluroscence; WB: - Western blotting 
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Table 12. List of Secondary Conjugated Antibodies 
 
Secondary Ab Company/Conjugation Used against Working conc. 
Goat-antimouse 
Invitrogen/AF 546 
Abcam  /HRP 
Hsc 73, anti-GFP 
1/1000 IF 
1/10,000 WB 
Goat anti Rabbit 
Invitrogen/AF 546 
sara gifted/HRP 
Lamp-2A, Lamp-
2B 
GAPDH 
1/1000 IF 
1/10,000 WB 
Goat anti Rat 
Invitrogen/AF 546 
Santacruzbiotech /HRP 
LAMP-1 
1/1000 IF 
1/10,000 WB 
Donkey anti Goat 
Invitrogen/AF 546 
Santacruzbiotech/HRP 
LIMP-II 
1/1000 IF 
1/10,000 WB 
 
 
Table 13. Solutions for SDS-Polyacrylamide gel 
 
Reagents 5% (Stacking gel) 10% (Resolving gel) 
Acrylamide (30%) 0.83 ml 3.3 ml 
H2O 3.4 ml 4.0 ml 
1.5M Tris, pH 8.8 - 2.5 ml 
1 M Tris, pH 6.8 0.63 ml - 
TEMED 0.005 ml 0.004 ml 
APS (10%) 0.05 ml 0.1 ml 
SDS (10%) 0.05 ml 0.1 ml 
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Table 14. Bacterial culture media 
L-Broth (Lennox, 1955) 
10 g/L Tryptone 
5 g/L yeast extract 
5 g/L NaCl 
pH 7 
Lennox Agar (Lennox, 1955) 
10 g/L Tryptone 
5 g/L yeast extract 
5 g/L NaCl 
15 g/L Agar 
M-9 glucose minimal media broth 
10X M9 salts 
20% Glucose 
1M MgSO4 
1 mg/ml Ca2+-Pantothenate 
1 mg/ml Thiamine 
0,5M CaCl2 
 
 
M-9 glucose minimal media agar 
 
 
 
 
10X M9 salts 
20% Glucose 
1M MgSO4 
1 mg/ml Ca2+-Pantothenate 
1 mg/ml Thiamine 
0,5M CaCl2 
1.5% agar 
DMEM/Ham´s cell culture medium agar 
with 10% FCS 
Dulbecco’s modified Eagle’s Medium 
(DMEM)/Ham’s F-12 salts (1:1) (Biochrom, 
Berlin) 10% fetal calf serum (heat inactivated 
at 56°C for 30 min.) 
15 g/L Agar 
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Protein studies 
SDS-PAGE 
APS-Stock solution       10% APS in H2O 
 
Coomassie-Staining solution      10% Acetic acid 
45% Methanol 
0.25% Coomassie Brilliant Blue R-250 
 
Coomassie-Destaining solution   10% Acetic acid 
       20% Methanol 
 
10X Running buffer       1.92 M Glycine 
250 mM Tris-HCl 
1% SDS 
 
2 x Loading buffer       10% Glycerin 
5% β-Mercaptoethanol 
3% SDS 
100 mM Tris-HCl 
          0.02% Bromphenolblue 
 
Plasmid preparation buffers 
E. coli 
Solution I      25mM Tris-HCl pH 8.0 
       50mM Glucose 
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       2mM EDTA 
 
Solution II      0.2 N NaOH   
       1% SDS 
 
Solution III      58.9g Potassium acetate 
       50ml Glacial acetic acid  
       200ml ddH2O  
 
Salmonella (Kado) 
10X Kado TE     42.5g Tris base 1000ml-1  
     7.5g EDTA 1000ml-1 
     in H2O, pH 7.9, autoclaved 
 
Kado Lysis Buffer     0.6g Tris base 100ml-1 
     3g SDS 100ml-1 
     in H2O, filter sterilized (0,45 µm)  
                   
 
Kado KOAc (Lösung III)    6ml of 5M KOAc 
     1.15ml of glacial HOAc 
     2.85ml ddH2O 
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Laboratory instruments 
Agarose gel electrophoresis tank   B1A and GE-B2, AGS, Heidelberg 
Agilent 2100 Bioanalyzer    Agilent Technologies, UK 
Aspirator      Vacuboy, neolab, heidelberg 
Autoclave      GTA16, Gössner, Hamburg 
Axon GenePix 4000AScanner   Axon Instruments, USA 
Centrifuges      Rotina 46R, Hettich Zentrifugen,  
       Tuttlingen 
       3K30, Sigma Laborzentrifugen, Osterode 
       5415D, eppendorf Zentrifugen, Engelsdorf 
       Avanti J-25, Beckmann Coulter, Krefeld 
Contrast microscope     Telaval 31, Zeiss, Jena  
Nanodrop      peqLab, Erlangen 
Electronic balance     BL3100, Sartorius, Göttingen 
Electronic precision weighing instrument  BP210S, Sartorius, Göttingen 
Electroporator      EasyjecT Prima, peqLab, Erlangen 
Electrophoresis power supply   PS 250, Hybaid, Lexington, USA 
Freezer -20 ºC      Liebherr comfort GS1313, Ochsenhausen 
Freezer -70 ºC      Advantage, Nunc, Wiesbaden 
Heating block      Thermomixer compact, Eppendorf,  
       Hamburg 
Hybridisation chambers    Anachem, UK 
Image-Dokumentation instrument   UV-Transilluminator UVT 28 MP,Camera 
E.A.S.Y. 429 K, Documentationssystem 
RM6, Herolab, Wiesloch 
Image-Dokumentation photo printer   P93E, Mitsubishi Electric, Ratingen 
Incubators      CB150, Binder, Tuttlingen 
       VT 5042 EK/N2, Heraeus, Hanau 
LABMATE Precision pipettes   ABIMED GmbH, Langenfeld 
Laser Scanning Confocal Microscope  Leica SP-II  
Magnetic stirrer     IKAMAG RET, Th. Karow, Berlin 
pH-Meter      Mikroprozessor pH-Meter 740, Knick, 
       Berlin 
Pipetting aid      Pipetus-akku, Hirschmann, Eberstadt 
Refrigerator      Privileg 4873, Quelle, Fürth 
Scanner      DUOSCAN T1200, AGFA, Köln 
SDS-PAGE-apparatus    Biorad, USA 
Shaking incubator     GFL3031, GFL, Burgwedel  
Spectrophotometer     Ultrospec 3000 pro, Amersham, Freiburg 
Sterile work bench     LaminAir HB 2448 and LB-48-C,  
       Heraeus Hanau 
Stratalinker      Stratagene, UK 
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Thermocycler      T3 Thermocycler, Biometra, Göttingen 
Vaccum pump     N735 AN18, KNF Neuberger, Freiburg 
Vortexer      MS2 Minishaker, IKA, Staufen 
Waterbath      Grant OLS 200, CLF Laborgeräte,  
       Burgwedel 
       E-5, Julabo, Seelbach 
 
Consumables 
 
Amicon ultra centrifugal filters   Millipore, Germany 
Cell culture flasks     Corning, Schiphol-Rijk, Netherland  
Cell scraper      Corning, Schiphol-Rijk, Netherland  
Nunc Cryotubes     Laborversand, Würzburg  
Disposable cuvettes     MBT, Giessen 
Disposable pipettes     Costar, Bodenheim 
Electroporation cuvettes    2 mm, peqLab, Erlangen 
Filter paper  Whatmanpaper 3MM, Schleicher and 
Schüll,  Dassel 
Pasteur pipettes     Roth, Karlsruhe 
Petriplates      Sarstedt, Nürnbrecht 
Sterile filters                            Rotilabo-Spritzenfilter 0.45 µm and 0.22 
µm pore size, Roth, Karlsruhe 
12-well cell culture plates    CellBIND, Corning, Schiphol-Rijk,  
       Netherland 
  
Reagents 
 
Acetic acid      Roth, Karlsruhe  
Acrylamide-Bisacrylamide-Solution,   RothKarlsruhe 
Rotiphorese Gel 30,    
Agar       Roth, Karlsruhe 
Agarose      Roth, Karlsruhe 
Alizarin yellow     Sigma-Aldrich, München 
Ammoniumpersulfate (APS)    Sigma-Aldrich, München 
Anhydrous 1,2-dichloroethane (DCE)  Sigma-Aldrich, UK 
Anhydrous succinic anhydride   Sigma-Aldrich, UK 
Antibiotics      Sigma-Aldrich, München  
L-Arabinose      Roth, Karlsruhe 
Boric acid      Roth, Karlsruhe 
Bovine serum albumin (BSA)   Sigma-Aldrich, München 
Bromophenol blue     Serva, Heidelberg 
5-Bromo-4-chloro-3-indolyl- 
â-D-galactoside (X-Gal)    Sigma-Aldrich, München 
Calcium chloride     Roth, Karlsruhe 
Chloroform      Merck, Darmstadt  
Supplements 
 
117 
 
Coomassie brilliant blue R250   Serva, Heidelberg 
Cy3       GE Healthcare Lifesciences, UK  
Cy5       GE Healthcare Lifesciences, UK 
Diethylpyrocarbonate (DEPC)   Sigma-Aldrich, München 
Dimethylsulfoxide (DMSO)    Roth, Karlsruhe 
Dithiothreitol (DTT)     Sigma-Aldrich, München 
DMEM/Ham’s F-12 salts medium   Biochrom, Berlin 
dNTPs       Roth, Karlsruhe 
Ethanol pure      Merck, Darmstadt  
Ethylenedinitrotetraacetic acid (EDTA)  Roth, Karlsruhe  
Ethylene-glycol-bis-tetraacetic acid (EGTA) Roth, Karlsruhe 
Fetal calf serum     PAN Biotech, Germany 
Gentamycin      Biochrom, Berlin 
Glucose      Sigma-Aldrich, München 
Glycerin      Roth, Karlsruhe 
HPLC grade water     Roth, Karlsruhe 
Iscoves modified DMEM    Biochrom, Berlin 
Isopropyl-β-D-thiogalactopyranoside (IPTG) Roth, Karlsruhe    
Magnesium chloride     Roth, Karlsruhe 
Magnesium sulphate     Roth, Karlsruhe 
Methanol      Roth, Karlsruhe 
Mowiol      Sigma-Aldrich, UK 
n-Methylimidazole     Sigma-Aldrich, UK 
o-Nitrophenyl-β-D-galactopyranosid (ONPG) Sigma-Aldrich, München 
PBS       Biochrom, Berlin 
Phenol       Roth, Karlsruhe 
Phenylmethylsulfonylfluoride (PMSF)  Roth, Karlsruhe 
Potassium chloride     Roth, Karlsruhe 
Random hexamers     Invitrogen, UK 
Sodium carbonate     Merck, Darmstadt 
Sodium chloride     Roth, Karlsruhe 
Sodium citrare     Sigma-Aldrich, München 
Sodium dihydrogen phosphate   Roth, Karlsruhe 
di-Sodium hydrogen phosphate   Roth, Karlsruhe  
Sodiumdodecyl sulfate(SDS)    Roth, Karlsruhe 
TEMED      Biorad, USA   
Tris Base      Sigma-Aldrich, München 
Triton X-100      Sigma-Aldrich, München 
Trypsin-EDTA     Biochrom, Berlin 
Tryptone      Roth, Karlsruhe 
Ultra-pure water     Sigma-Aldrich, UK 
Wasserblau/Anilin blue    Fluka-Riedel-de Haën, Seelze 
Xylene cyanol      Fluka-Riedel-de Haën, Seelze 
Yeast extract      Roth, Karlsruhe  
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Commercial Kits 
 
Abgene Extensor Hi-Fidelity PCR master mix Thermo Scientific, UK 
BCA Protein Assay Kit    Pierce, USA 
BioPrime® DNA labeling system   Invitrogen, UK 
100 bp-DNA Ladder     Roth, Karlsruhe  
Lambda HindIII marker    Roth, Karlsruhe 
Nanoparticles      TurboBeads, Zürich  
Protein molecular weight marker VII-L  Sigma-Aldrich, München 
Protino® Ni-TED column    Machery-Nagel, Düren 
QIAGEN Plasmid Midi Kit    Qiagen, Hilden 
QIAGEN Genomic DNA preparation kit  Qiagen, Hilden 
Qia-quick PCR purification kit   Qiagen, UK 
 
Enzymes 
 
Bio Therm Taq-Polymerase    Rapidozym, Berlin 
DNA-Restriction enzymes    Promega, Mannheim 
Lysozyme      Roth, Karlsruhe 
RNase free DNase     Promega, UK  
T4 DNA-Ligase     Promrga, Mannheim 
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